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Summary 
 
The NS culture system is an innovative yet not fully characterized method of 
culturing neural stem cells (NSCs). Previous reports have described the possibility of 
isolation of a virtually pure NSC culture from embryonic, fetal or adult NSCs (Conti et 
al., 2005; Pollard et al., 2006; Sun et al., 2008). These cells, grown in adhesion, are 
called NS cells and show radial glial characteristics. The present thesis aims to 
characterize the in vitro and in vivo behaviour of human and mouse NS cells. 
 
In the first study, we describe the isolation of a new strain of human striatal NS 
cells. They show unique features in vitro, and can be efficiently differentiated into 
neurons. After transplantation in newborn rats, they survive, migrate and differentiate 
in the host brain. 
 
In the second part of the thesis, we show that mouse ES-derived NS cells fuse with 
cortical pyramidal neurons after transplantation in mice or rats. This process is 
mediated by microglia, which first fuse with the NS cells and then with the neurons. 
This NS-microglia-neuron fusion has not been previously described, although it 
 occurs both in vivo and in vitro. 
 
In summary, we report here previously undescribed features of the NS cells; our 
results are relevant to better understanding of NSCs in general and their behaviour 
after transplantation in the brain. 
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Riassunto della Tesi 
 
Una cellula staminale neurale (neural stem cell - NSC) è in grado di autoreplicarsi e 
di dar origine ai tre tipi cellulari propri del sistema nervoso (neuroni, astrociti e 
oligodendrociti). Cellule di questo tipo possono essere isolate sia dal tessuto fetale che 
adulto. Recentemente (Conti et al, 2005) è stato descritto un innovativo sistema di 
coltura per NSCs, caratterizzato dalla crescita in adesione. Le cellule isolate in questo 
modo vengono chiamate "NS" e hanno delle proprietà distinte da altre colture di NSC, 
sia in vitro che in vivo. Nella presente tesi ci si è proposti di caratterizzare diversi 
aspetti del comportamento delle cellule NS, sia murine che umane. 
Il primo studio di questa tesi riguarda cellule NS di origine umana. Abbiamo isolato 
le cellule staminali neurali dallo striato fetale, e quindi le abbiamo coltivate in 
aderenza, procedendo poi alla loro caratterizzazione in vivo ed in vitro. Le cellule 
derivate (human NS - hNS) si sono dimostrate molto interessanti, dando origine ad 
un'alta percentuale di neuroni in vitro, compresi alcuni tipi neuronali specifici dello 
striato. Dopo il trapianto in ratti neonati, le hNS hanno dimostrato la capacità di 
sopravvivere, migrare e dare origine ad un grande numero di neuroblasti. 
Nel secondo lavoro presentato qui, abbiamo studiato il comportamento di una linea 
di cellule NS derivata da cellule staminali embrionali di topo (mNS). Abbiamo 
trapiantato le mNS-GFP in topi e ratti neonati, e abbiamo osservato, in corteccia, la 
presenza di neuroni piramidali GFP positivi. Questi sono in realtà il risultato della 
fusione tra le mNS e elementi del cervello ricevente. Per approfondire questo aspetto, 
abbiamo analizzato una serie di cocolture, dove abbiamo confermato la fusione delle 
mNS con neuroni primari. Da un'analisi più accurata, è risultato che questo fenomeno 
in realtà avviene in due passaggi successivi: per prima cosa la cellula mNS si fonde 
con una microglia; questa a sua volta si può fondere con un neurone. 
Nel complesso, la presente tesi approfondisce alcune caratteristiche prima non note 
delle NSC; studi di questo genere sono necessari al fine di comprendere meglio il 
comportamento di queste cellule e le interazioni tra le cellule trapiantate ed il cervello 
ospite. 
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1 - Introduction 
 
 
 
1.1 - Neural stem cells 
 
 
General definitions 
 
Neural stem cells (NSCs) are self-renewing, multipotent cells with the capability of 
giving origin to neurons, astrocytes and oligodendrocytes (Gage, 2000) (fig 1.1). Such 
cells are present in the developing and adult brain, or can be derived from embryonic 
stem cells (ESCs); they represent both an interesting model to study neural tissue and a 
promising source of material for cell-based therapeutic approaches. 
Amongst the characteristics of a NSC, and of a stem cell in general, is the 
capability to give rise to a cell identical to itself after cell division; this can be 
symmetrical, giving origin to two identical daughter stem cells, or asymmetrical, 
resulting in one stem cell and one progenitor, a cell more committed towards a certain 
fate.  
This transition, in stem cells, is more easily explained by the concept of potency; 
this is an indication of how many cell types can be generated from a given stem cell. 
The fecundated egg, or zygote, is totipotent, as it can give rise to any cell of the body; 
it is not, by definition, a stem cell, since it cannot self-replicate. In the inner cell mass 
of the blastocyst, embryonic stem cells (ESCs) are defined as pluripotent, indicating 
that the cells of any of the three germ layers can be generated from them. They are not 
totipotent, since they cannot give rise to the embryonic part of the placenta. 
Multipotent cells are characteristic of the different tissues of the body, both during 
development and, in some cases, in adult life; these cells are capable of giving origin 
to various cell types in the specific lineage to which they belong. In this category fall 
the NSCs, as from them can be generated only cells of the neural lineage, namely 
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neurons, astrocytes and oligodendrocytes. From multipotent stem cells will originate 
the different kind of progenitors, which are said to be unipotent, since they can give 
rise to only one cell type. These cells often have a limited self-renewal capacity, but 
will eventually generate post-mitotic cells, which will compose the mature tissues. In 
the context of potency, it is worth mentioning, for the sake of the present discussion, 
the concept of transdifferentiation. This term indicates the capacity of an adult 
multipotent stem cell to acquire a broader differentiation potential, and to give origin 
to cells of germ layers other than its own. To date, there is no experimental evidence 
that this can actually occur, but rather, it is a concept sprung from the misinterpretation 
of other phenomena (Rodic et al., 2004).  
When defining stem cells, it is worth mentioning the iPSCs (induced pluripotent 
stem cells), in which pluripotency is induced in somatic cells by the overexpression 
four factors (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). The 
development of this technique opened a vast number of opportunities to the 
researchers, for the possibility of reprogramming any adult cell, murine or human, to a 
pluripotent state. In the same line falls the recent description of a somewhat similar 
protocol to convert fibroblasts into mature, functional neurons, using three 
transcription factors (Vierbuchen et al., 2010). These induced neuronal (iN) cells 
showed the intriguing possibility of converting any cell into a neuron and revealed that 
epigenetic modifications that occur during development can be reversed and diverted 
to a given phenotype without passing through the pluripotent state.  
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Figure 1.1 - Stem cells and their neural potential. Schematic representation of stem 
cells with the capability of giving rise to cells in the neural lineage. The hierarchical 
representation reflects both the normal development and the degree of potency they 
possess (modified from (Gage, 2000)). 
 
Origin and characteristics of NSCs 
 
Development of NSCs - By definition, NSCs are essentially the stem cells of the 
nervous system. As mentioned above, they can be found in the developing CNS and in 
confined areas of the adult brain. It eludes the purposes of the present thesis to 
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describe in detail the development of the mammalian brain, but notions of some of the 
processes and the players involved will be propaedeutic for the understanding of the 
results presented; therefore, only some basic concepts will be described here. 
Ultimately, neurons and macroglia (i.e. astrocytes and oligodendrocytes) are 
derived from a pseudostratified neuroepithelium of ectodermal origin that lines in the 
cerebral ventricles in early development (Alvarez-Buylla et al., 2001; Temple, 2001; 
Kriegstein and Alvarez-Buylla, 2009) (fig 1.2). Around the embryonic days 9-10 (E 9-
10) in the mouse cortex, the neuroepithelial cells begin to acquire a very distinct 
morphology, maintaining their cell body in the ventricular zone (VZ), but emitting 
processes that are in contact with both the ventricular and the pial surfaces. As the 
cortex thickens, these cells prolong their pial processes, which are disposed in a radial 
fashion. Moreover, they express a set of markers classically thought to be 
characteristic of glial cells, such as astrocyte-specific glutamate transporter (GLAST), 
brain lipid-binding protein (BLBP), Tenascin C, and glial fibrillary acidic protein 
(GFAP) (in humans); they are called Radial Glia (RG) (for review, see (Gotz and 
Barde, 2005)). Besides the mentioned proteins, RG cells express some specific 
intermediate filaments, like Vimentin, the RC1 and RC2 epitopes and Nestin. Several 
studies show that RGs are the ultimate precursors throughout the CNS (Anthony et al., 
2004) and give origin to the NSCs in the adult brain (Merkle et al., 2004). In addtion 
to their role as stem cells, RGs serve also the function of allowing newly formed 
neuroblasts to migrate and reach their appropriate location during development 
(Kriegstein and Alvarez-Buylla, 2009). What has been described here for the cortex, 
can be applied for several other regions of the developing brain (Kriegstein and 
Alvarez-Buylla, 2009). RG cells generate progenitors, by asymmetric divisions, and 
these progenitors will in turn divide a limited number of time to give origin to post-
mitotic neurons (or macroglial cells) or to other progenitors. After the formation of the 
CNS is completed, RGs retract their pial processes and, while many differentiate, 
some retain their stem cell characteristics and continue to give rise to new neurons and 
macroglia throughout adult life, becoming adult NSCs. 
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Figure 1.2 - Origin and glial nature of NSCs. Developmental stages are represented 
from left to right, starting from neuroepithelial cells, which then produce radial glial 
cells. An alternation of asymmetric and symmetric cell divisions, accounts for the 
formation of neurons, macroglia and new RGs. These will eventually change their 
characteristics, going to form the adult NSC population (modified from (Kriegstein 
and Alvarez-Buylla, 2009)). 
 
Adult neurogenesis - A description of the characteristics of NSCs cannot be 
complete without mentioning those that reside in the adult brain. The research in this 
field has greatly influenced the study of fetal and embryonic stem cells, defining 
concepts like stem cell niche and showing several mechanisms that influence NSCs in 
general. Moreover, historically, a great deal of the work done to develop techniques 
and assays was done on adult stem cells.  
For more than 100 years, it was a shared opinion in the scientific community that 
there was no formation of new neurons in the adult life (see (Gross, 2000; Chojnacki 
et al., 2009) for comprehensive review). Pioneering work by Altman and Das (Altman 
and Das, 1965), showed instead that in the rat hippocampus, adult-born cells (labeled 
with tritiated thymidine - H3T) had the morphology of neurons. Notwithstanding this 
discovery, the concept of adult neurogenesis was ignored for two decades. Following 
reports on rat (Kaplan and Hinds, 1977) and song birds (Goldman and Nottebohm, 
1983) showed similar outcome, but the negative results in the work conducted on 
primates by Pasko Rackic (Rakic, 1985b, a), had a profound influence on the field, 
putting yet another conceptual prejudice on the idea that new neurons could be born in 
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the adult brain. Finally, technical advancement, which involved the use of bromo-2-
deoxyuridine (BrdU) instead of H3T, and fluorescent double labeling, permitted the 
definitive demonstration of the adult neurogenesis in rat (Kuhn et al., 1996) and 
human (Eriksson et al., 1998). The in vitro study of the NSCs had a great contribution 
in the establishment of this concept (see below).  
In the adult mammalian brain, it is generally thought that neurogenesis is confined 
to two specific regions: the dentate gyrus of the hippocampus and the subventricular 
zone (SVZ). In the first, NSCs in the subgranular zone (SGZ) proliferate generating 
intermediate progenitors, which proliferate more markedly. These, in turn, give rise to 
neuroblasts, which migrate and differentiate into mature granule cells, projecting to 
the appropriate targets in CA3 and functionally integrating in the circuitry (van Praag 
et al., 2002). In the SVZ the scenario is very similar: quiescent stem cells (called B-
type cell) divide seldom, giving origin to rapidly dividing "transit amplifying" C-type 
cells. From these, the neuroblasts, A-type cells, are generated and they migrate along 
the rostral migratory stream (RMS) to the olfactory bulb, where they differentiate into 
mature interneurons.  
The neurogenic process in these two areas is now well accepted and has risen up a 
considerable research interest, especially for its possible functional implications. 
Indeed, it has been suggested that the new neurons are involved, for example, in 
learning and memory (Gould et al., 1999), stress (Gould et al., 1997) and depressive 
behaviour (Malberg et al., 2000). Moreover, several pathologies modify the rate of 
neurogenesis, for example stroke (Arvidsson et al., 2002) and epilepsy (Parent et al., 
1997), amongst others.  
The functional importance of adult neurogenesis remains to be demonstrated; 
nevertheless it is a very intriguing phenomenon and the knowledge on this topic has 
greatly influenced research on the field of NSCs. 
INTRODUCTION  
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Ways of study of NSCs - One major difficulty in studying NSCs is the lack of an 
unambiguous marker. All currently used and proposed markers, are expressed by 
various cell types, and only the combination of several of these markers can allow 
reliable identification of a NSC. Alternatively, the location of a cell, together with 
some other characteristic (e.g. proliferation) can indicate its stem cell nature. Some of 
the most widely used markers for immunostaining of NSCs are Nestin (Lendahl et al., 
1990), Sox2 (Uwanogho et al., 1995), Musashi 1 (Nakamura et al., 1994) and CD133 
(Uchida et al., 2000); but none of these are solely present on stem cells. Genetically 
engineered cells or animals can be used, but also in this case there is no unique locus. 
One part of the nestin promoter/enhancer (Lothian et al., 1999) is so far the most 
reliable in showing expression specifically in NSCs. One way of studying stem cells, 
is analysing their descendents (i.e. the neuroblasts that are derived from them). For 
these, better markers are available and widely accepted; for example, doublecortin 
(DCX) or PSA-NCAM are commonly used to identify these cells.  
In the late 1980s and early 90s, the aforementioned discovery, or re-discovery, of 
adult neurogenesis in vertebrate, mammalian and human brain, gave great importance 
to the study of NSCs as means of analysis of this phenomenon. Concurrently, 
pioneering work on transplantation in patients with Parkinson's Disease (PD) (Lindvall 
et al., 1990) aroused the attention of the scientific community towards the possibility 
of replacing neurons that die during neurodegenerative diseases. This, in turn, gave 
attention to NSCs, as source of material to graft, alternative to the fetal tissue used in 
those studies. The lack of markers for these cells, which still stands nowadays, 
rendered difficult their analysis, and has forced researchers to find other ways to 
identify them.  
Together, these needs have urged the development of methods to cultivate and 
study the NSCs, to analyze their characteristics in vitro and in vivo.  
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NSCs in vitro 
 
Neurospheres cultures - The seminal work of Reynolds and Weiss (Reynolds and 
Weiss, 1992) showed that the NSCs can be maintained in culture like neurospheres, 
floating aggregates of cells at different stages of neural commitment, including stem 
cells. These spheres can be dissociated and after replating the NSCs will give rise to 
new neurospheres, allowing the culture to be perpetuated. A key factor for the 
maintenance of these cultures is the presence of epidermal growth factor (EGF) and 
basic fibroblast growth factor (bFGF or FGF2), which drive the proliferation of the 
NSCs and keep them in an undifferentiated state. After this landmark finding, many 
other laboratories, including ours, used the neurosphere culturing method to isolate 
and propagate NSCs, of murine and human (Svendsen et al., 1998) origin.  
The development of the neurosphere culture system led to the optimization of the 
so-called neurosphere assay (NSA). This is based on the assumption that the number 
of neurospheres in a culture is a reflection of the number NSCs plated. Therefore, it is 
possible to gauge the presence and/or the quantity of stem cells in a given part of the 
CNS by quantifying the clonally-derived neurospheres that are generated from it. 
Upon passaging, up to 90% of the re-plated cells die, and only the neurosphere-
forming cells, by assumption the NSCs, will proliferate and give origin to new 
spheres. These new neurospheres, called secondary, are an indication of the 
proliferative capacity of the NSCs themselves, besides being a further demonstration 
of their stemness. 
To demonstrate that the neurosphere-forming cells are indeed NSCs, it is necessary 
to demonstrate that all of the three CNS cell types can be generated from them. This is 
typically achieved with the removal of the growth factors and addition of fetal bovine 
serum (FBS), which helps the survival of the cells during differentiation. After a 
certain amount of time, variable across the studies, some of the cells will start to 
express specific markers for neurons, astrocytes or oligodendrocytes, identifying the 
original cells as tripotent.  
A further demonstration of the stem cell nature of the cells in the neurospheres is 
the clonogenic assay; it is possible to obtain cultures derived from single cells, isolated 
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by serial dilution or FACS (fluorescence activated cell sorting). These cultures are said 
to be clonal, and the cells in them are supposedly all alike; technically, the 
demonstration of tripotency of these cultures is the ultimate proof to call a cell neural 
stem cell.  
Although still widely used, and almost non-substitutable for the NSA, neurosphere 
cultures present some caveats. Firstly, after extensive passaging, their replicative and 
neurogenic characteristics tend to diminish (Ostenfeld et al., 2000; Reynolds and 
Rietze, 2005), although leukemia inhibitory factor (LIF) has been shown to reduce this 
effect (Villa et al., 2001). One other major problem with neurospheres is that the 
composition of the spheres themselves remains largely unknown. As mentioned above, 
they are believed to contain a mixture of cells at different stages of neural and glial 
differentiation, from neuroblasts to post-mitotic cells, while the true NSCs are 
probably just the 5% of the whole sphere. This complex population does not allow for 
isolation of the specific effects of manipulations on the stem cells, and raises the 
question of what role non-stem cell components have in creating a niche for the NSCs. 
Lastly, the relation NSC → neurosphere is not necessarily 1:1, as is assumed when 
performing a NSA; indeed, even at lower than clonal densities, cells can aggregate 
with each other, and therefore the spheres will not be derived from the replication of a 
single NSC (Reynolds and Rietze, 2005). 
Nonetheless, these cultures have represented the point of reference for all the 
culturing methods that followed, and are still an extremely valid model of study.  
 
Adherent NSCs cultures - There are several advantages to culturing cells in 
adhesion rather than floating, including ease of tracking individual cells, in controlling 
the growth conditions and in performing cytochemical analysis. Therefore, several 
methods of growing NSCs as monolayer cultures have been attempted over the last 20 
years, even before the development of neurospheres.  
Early work was performed using different supplements in the medium, including 
FBS (Temple, 1989), nerve growth factor (NGF) (Cattaneo and McKay, 1990), bFGF 
or EGF , alone or in combination, to maintain progenitors in culture for a limited 
amount of time (Ray et al., 1993). Afterwards, several reports described that it was 
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possible to grow stem/progenitor cells from embryonic CNS or neurogenic areas in the 
adult brain (Palmer et al., 1995). These cultures, though, were stable only over a 
limited number of passages, since they divide asymmetrically and their potential to 
generate neurons faded over time (Chenn and McConnell, 1995; Shen et al., 2002).  
A method that has been widely used to maintain stable cultures of neural 
stem/progenitor cells is immortalization. This was initially induced through 
polyethylene glycol (PEG)- induced fusion with a transformed cell line; the resulting 
hybridoma could be grown indefinitely and would maintain some features of the 
parental neuronal cell (Hammond et al., 1986). Cells derived from the murine 
(Frederiksen et al., 1988; Renfranz et al., 1991) or human (Sah et al., 1997) developing 
CNS have been also immortalized using viral oncogenes, such as SV40 largeT or v-
myc. These cell lines were shown to retain a lot of the characteristics of the NSCs, and 
it was often demonstrated that the oncogene was downregulated upon differentiation 
(Cacci et al., 2007), allowing for extensive study in vitro and also after transplantation. 
Nonetheless, the presence of a genetic alteration, makes immortalized cell lines a 
suboptimal model, because of the modification in the expression of other factors it 
may entail. Moreover, the increasing interest of the scientific community in the in vivo 
behaviour of these cells, in prospects of cell therapy, forced the seeking of different 
approaches; indeed, the possibility of tumorigenicity of the grafted cells is, of course, 
increased by the presence of an oncogene.  
 
ES-derived NSCs - Embryonic stem cells (ESCs) represent a virtually unlimited 
source of pluripotent cells, which can, with opportune culturing conditions, be directed 
to assume a neural fate.  
In general, it is possible to derive neurons from ESCs by either exposing them to 
retinoic acid (Glaser and Brustle, 2005) or by making them grow into free floating 
aggregates of cells named embryoid bodies, which upon replating will form neural 
rosettes, which have characteristics of NSCs (for a review see (Krencik and Zhang, 
2006)). In either case, a neural fate seems to be somehow the default destiny of  ESCs. 
Besides the differentiation of these cells into neurons, the derivation of cells that can 
be transplanted has posed some further challenges to researchers. 
INTRODUCTION  
17 
The major problem in deriving neural cells from ESCs is connected to the mixed 
character of the resulting cultures. During initial phases, undifferentiated ESCs are 
present along with committed neural progenitors. If such cells are grafted, they 
invariably give rise to the formation of teratomas (Ostenfeld et al., 2000). As the cells 
are kept in vitro for a longer time, presumably committing all the culture towards the 
desirable fate, most of the cells become post-mitotic and tend to die after 
transplantation. Many researchers have tried to address this problem, and the NS cells 
discussed into more details below represent one of the successful attempts (Conti et 
al., 2005). Elkabetz et al. (Elkabetz et al., 2008) were able to isolate and grow in 
culture cells at an early neuroepithelial stage, called rosette-NSCs (R-NSCs). Though 
these cells had very interesting features in vitro, they gave rise to overgrowth in vivo, 
making them not suitable for transplantation purposes. More recently, Koch et al. 
(Koch et al., 2009b), derived long term-stable NSCs from ESCs, using a similar 
approach; briefly, they derived neurorosettes, but then isolated them, letting them 
grow as floating aggregates. Once replated, these cells grew as a monolayer, and were 
composed of a pure population of neural cells, stable over a high number of passages. 
Moreover, these cells seemed to have remarkable in vivo characteristics, in terms of 
differentiation and integration, without signs of tumor formation. Although these cells 
were apparently committed to a ventral anterior hindbrain fate, the authors managed to 
divert them to a ventral midbrain phenotype, though with a poorer efficiency.  
In the recent years, "induced pluripotent stem cells" iPSCs, have been subjected to 
great interest, because of the appealing possibility to convert an adult somatic cell into 
a pluripotent one (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). This 
amazing advance in stem cell biology has been paralleled by the adjustment of the 
protocols for derivation of neural cells developed for ESCs, to the iPSCs. Only few 
reports are available to date (Onorati et al., 2009), but these cells will probably be the 
protagonists of the (near) future in this field.  
 
NS cells - The major advancement in the culture of NSCs since the description of 
the neurosphere culture 15 years ago, was achieved by Conti et al. in 2005 (Conti et 
al., 2005). Their initial definition of a method to derive and maintain monolayer 
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cultures of neural stem (NS) cells from ESCs, was followed by the adjustment of this 
protocol to obtain similar cultures from fetal and adults NSCs (Pollard et al., 2006), 
including human (Sun et al., 2008). This series of articles showed that it was not only 
possible to have adherent cultures of these cells, but that they had increased 
neurogenic potential in these conditions. As these NS cells are the main focus of the 
present thesis, I will discuss here their characteristics in details.  
In their first paper, the authors started from a standard protocol for derivation of 
neural precursors from mouse ESCs; they then used specific serum-free media (NS-A, 
nowadays renamed Euromed-N) that does not allow the proliferation of 
undifferentiated ESCs. The neural cells formed floating aggregates which the authors 
harvested and replated. The culture that resulted turned out to be stable, highly 
proliferative, and easy to differentiate into neurons or astrocytes. Interestingly, these 
cells, in proliferation, expressed a set of markers characteristic of radial glia, such as 
Nestin, Vimentin, RC2 antigen, BLBP, Sox2, Pax6 and GLAST, with the notable 
exception of GFAP. They also expressed more generic markers of NSCs, such as 
Olig2 and CD133, while they lacked the expression of pluripotency markers like Oct-4 
and Nanog, and of mesoderm and endoderm markers, indicating their complete 
commitment to the neural lineage. The authors derived clonal cultures by serial 
dilution, and obtained several lines with similar characteristics from different ES lines. 
They then proceeded to applying the NS culturing protocol to cells of fetal origin; they 
used either a single cell suspension of the tissue, or neurosphere cultures, plating them 
on gelatin-coated dishes, which do not allow the adhesion of differentiated cells. The 
fetal-derived NS cells showed all the characteristics of the ESCs-derived counterparts, 
although with a reduced proliferative behaviour. In contrast to neurospheres, these 
cultures were composed of a virtually pure population of NSCs.  
With appropriate methods, the authors showed that it was possible to differentiate 
these cells into γ-amino-butyric acid(GABA)-ergic neurons, capable of firing action 
potentials. After 4 weeks, roughly 40% of the cells were expressing neuronal markers 
like Tuj1 or MAP2. Moreover, in presence of FBS, they could efficiently become 
astrocytes, showing that these cells were at least bi-potent. A series of transplantation 
in intact animals (in utero, neonatal rats and adult mice) demonstrated that the NS 
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cells could behave as NSCs in vivo as well, differentiating into astrocytes and neurons, 
although the authors do not study their in vivo characteristics in detail.  
Overall, the NS cells had three remarkable characteristics: 1) they could grow as an 
adherent monolayer, and were not dependent on the surrounding cells to provide them 
with a specific niche, as happens with neurospheres; 2) they were dividing 
symmetrically, giving a very stable population and producing a virtually unlimited 
amount of cells; 3) after differentiation, they could give rise to an unmatched (at the 
time) quantity of neurons, which were electrophysiologically functional.  
In subsequent publications, the same group of authors added some experimental 
results to the picture, extending the limits of the NS-culturing system. Firstly, they 
were able to derive NS cells with similar characteristics from adult tissue (Pollard et 
al., 2006), specifically from adult mouse SVZ. This suggested that the method was 
responsible for the behaviour of NS cells, rather than their origin.  
A final confirmation that the NS cells were truly tripotent stem cells came with the 
demonstration that they could differentiate into oligodendrocytes (Glaser et al., 2007), 
as well as neurons and astrocytes; a requirement for NSCs, as explained above. The 
authors used a serum-free medium of defined composition, to show that they could 
prime the NS cells towards the oligodendrocytic fate, both in vitro and in vivo.  
More recently, Spiliotopoulos et al. (Spiliotopoulos et al., 2009) refined the 
differentiation protocol for the ES-derived NS cells, applying a number of different 
combinations of growth/neurotrophic factors, media and coating. The resulting method 
allowed them to obtain a very high percentage of neurons in the cultures (85% Tuj1 
positive), and to get improved survival of the differentiating cells. As shown in initial 
publications, most of these cells express GABA, and fail to be stained with markers 
for any other neuronal subtype.  
Although briefly reported in the first publication, the first characterization of NS 
cells of human origin was shown in 2008 (Sun et al., 2008). In this case the authors 
described an alternative method of isolation of the NS cells; instead of allowing the 
cells to form primary neurospheres, and then letting them attach to a gelatin-coated 
surface, Sun and coworkers plated the dissociated striatal fetal tissue directly on dishes 
coated with laminin. A subsequent period (7-10 days) on gelatin plates, ensured the 
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enrichment in undifferentiated precursors. The authors claimed that this method was 
more efficient than the one they adopted previously, though they do not elaborate this 
statement or corroborate it with quantitative or qualitative data. In general, the 
characteristics of these human NS (hNS) are very similar to the ones of their mouse 
counterparts, in the expression of markers and in vitro behaviour. The major 
differences consisted of the proliferation rate (hNS have a sensibly longer dubbing 
time, around 6 days) and in the expression of GFAP, not found in mouse NS. The 
latter observation is consistent with the radial glia nature of the hNS cells, since it is 
known that the human GFAP promoter is active in RGs (Malatesta et al., 2000). The 
authors then analysed the requirements for hNS to proliferate, in terms of coating and 
growth factors, pointing out that they did not require LIF for long term stability. Also 
in this case, the hNS were similar overall to their mouse counterparts, though they 
were shown to be more dependent on the presence of bFGF in the medium. Upon 
differentiation, these cells could generate astrocytes, oligodendrocytes and neurons, 
the latter characterized by the expression of Tuj1 (43% after differentiation), MAP2, 
or DCX. The yield in neurons could be augmented if the cells were selected for the 
neuroblast marker PSA-NCAM, reaching roughly the 65%. The neuronal cells 
obtained from these hNS, however, failed to express any neuronal subtype marker 
tested (by immunostaining or RT-PCR) but calretinin (5% of Tuj1+). Namely, they 
were negative for GABA, Calbindin, Parvalbumin, DARPP-32, NPY, GAD67, Islet-1, 
TH and ChAT. These last observations raise a question as to the nature of these hNS-
derived neuronal cells (that nonetheless were able to fire action potentials). One 
possibility is that these cells are glutamatergic, since the authors did not check for this 
subtype. This is unlikely, as previous observations (Kallur et al., 2006) have shown 
that cells of striatal origin tend to maintain their commitment and give rise to GABA-
ergic interneurons. The alternative is that the hNS are not capable of fully 
differentiating in vitro, at least with the methods tested. Sun et al. did not perform any 
transplantation study, and therefore there is no information on their in vivo behaviour.  
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Figure 1.3 - NSCs that can be propagated. The cartoon parallels the stages in CNS 
development with cells that have similar characteristics and can be cultured; the 
different methods of derivation and propagation of NSCs described in the text, make 
these cells very different amongst each other, and assuming the characteristic of cells 
that can be found during development (modified from (Conti and Cattaneo, 2010)). 
 
 
Transplantation of NSCs 
 
A major part of the studies carried out on NSCs aim to determine how they react 
when placed in the brain. The discussion of this topic cannot abstract from the 
description of the first studies performed in the 1970s and 80s using postmitotic 
neuroblasts, which also led to the application of these methods in human pathology.  
 
Transplantation of neuroblasts - It has long been known that tissue from the 
developing brain has the capacity of give rise to mature neurons, retaining a great 
plasticity at the same time. The turning point in this field was achieved by using 
single-cell suspension instead of tissue fragments for the implantation in animal brain 
(Gage et al., 1983; Gage and Bjorklund, 1984). This rapidly led to refinement of the 
technique, and to the study of transplantation of fetal precursors in rodent models of 
pathology, notably Parkinson's disease (PD) (Brundin et al., 1986), until it was tried on 
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patients, with positive functional effects (Lindvall et al., 1990). Subsequent trials, 
however, did not replicate these results, for a number of reasons (cell number, patient 
selection criteria, above all) and this had a negative influence on the field at large 
(Freed et al., 2001; Olanow et al., 2003). Nonetheless, these early experiments proved 
that it was possible to replace neurons which had died during a pathology with 
immature ones and then observe a positive functional outcome. Such achievement 
opened the field of neural transplantation, and increasing knowledge on NSCs has 
allowed for the transposition of what had been learnt with fetal grafts to the 
transplantation of stem cells and their derivatives.  
 
NSCs grafted in the intact brain - The transplantation of NSCs in animal models is 
considered to be a crucial step in the characterization of the different cell lines or 
strains. The features of certain cells in vitro are determined by the factors present in 
the culture system, including media, surface adhesion and cell-cell interaction. All 
these factors are radically different in vivo, and the study of the behaviour of a given 
NSC after transplantation aids in highlighting its characteristics. Even while many 
papers in the literature report the isolation and characterization of the cells in vitro 
along with the study of their implantation, it is still very difficult to draw general 
conclusions. The parameters typically investigated are survival and differentiation of 
the cells. Regarding the first, a horizontal reading through the literature reveals that 
only between 20 and 60% of the implanted NSCs survive, even in absence of immune 
reaction; it is conceivable that the remaining cells die because of the transplantation 
procedure itself. When it comes to differentiation, the most common feature analysed 
is the neuronal, generally using immunostaining to study the expression of certain 
markers by the grafted cells. This could involve the analysis of the time course of the 
differentiation (for example see (Kallur et al., 2006)), the rate at which it occurs, or the 
type of neurons produced. The latter analysis is usually directed to find specific 
neuronal subtypes of the brain region where the NSCs were implanted (i.e. medium 
spiny neurons in the striatum, pyramidal neurons in the cortex, granule cells in the 
hippocampus, etc). It is generally less frequent to find reports about the differentiation 
in astrocytes or oligodendrocytes, although the latter has a particular relevance in 
INTRODUCTION  
23 
multiple sclerosis models. One aspect of NSCs transplantation that is often overlooked 
is the possibility that these cells fuse (see below); isolated articles (Lundberg et al., 
2002; Gaillard et al., 2007; Ideguchi et al., 2010) have reported the absence of cell 
fusion, with more or less reliable methods, but overall this kind of outcome is not even 
analysed in most studies. 
Transplantation studies can be divided based on the type of host that is chosen; 
when animal cells are used, a syngenic transplantation is usually chosen, to avoid the 
rejection of the graft; this typically happens with mouse cells. An alternative is to use 
neonatal recipients, because the immune system is still immature and the implanted 
cells usually survive (Kelly et al., 2009). Along with the rejection aspects, newborn 
animals have the advantage of the higher degree of plasticity in the CNS; this results, 
usually, in a better integration of the grafts, regarding both survival and differentiation 
of the cells. This is the approach used in the present thesis, where NS cells have been 
transplanted in mouse or rat neonates. To bypass the immunorejection problem, 
immunodeficient animals, like SCID (severe combined immunodeficiency) mice and 
nude rats or mice, have been used. In general these animals are suitable for long term 
studies, or whenever human cells are involved. Indeed they guarantee the best 
survival, without the general characteristics of the cells being affected. 
As discussed below, transplantation in intact adult animals sometimes leads to poor 
cell survival and maturation, possibly because of the non-permissive environment. 
One notable exception is when cells are implanted into neurogenic areas (Fricker et 
al., 1999; Englund et al., 2002); this indeed has been proven to be beneficial for 
survival, migration and differentiation, probably because of the factors present in the 
specific niches, which naturally support newly formed cells.  
 
Transplantation in models of neurodegeneration - As mentioned above, the ultimate 
goal of the research in the field of NSCs is to develop a feasible source for 
transplantation in patients: so called cell therapy. This is a mere concept more than an 
actual therapeutic intervention; several steps need to be fulfilled before its realization, 
from practical and ethical points of view (Hyun et al., 2008). Various issues, like the 
selection of the subjects and of safe cells sources (Ahrlund-Richter et al., 2009), 
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though important, are not strictly relevant to the present work (for comprehensive 
reviews on the subject of clinical translation of NSCs research see (Lindvall et al., 
2004; Lindvall and Kokaia, 2006; Koch et al., 2009a; Lindvall and Kokaia, 2010)). 
Nonetheless, some aspects of grafting in pathological models can shed light on the 
biology of NSCs themselves. This will be dealt with here. 
One interesting observation is that NSCs can survive better in a lesioned 
environment; this aspect has been taken for granted for a long time, after early reports 
on neuroblast grafting suggested the concept (Shihabuddin et al., 1996). Recently, our 
lab studied this aspect in more details, showing that the survival of the same kind of 
hNSCs implanted in intact or stroke-damaged brain, was greatly affected by the lesion; 
survival being higher in the latter case (Darsalia et al., 2010). In the same article, we 
showed that the environment that the cells find changes with the progression of the 
pathology, leading to differences in the differentiation of the cells, along with their 
survival.  
In general, researchers have looked for two aspects when dealing with 
transplantation in animal models of neurodegenerative diseases: 1) cell replacement, 
i.e. the differentiation of the implanted cells into the cell type lost in the pathology and 
2) functional recovery of the animal, due to the transplantation. While the first has 
often been demonstrated (e.g. (Darsalia et al., 2007)), the recovery of function is not 
always addressed or found, though demonstrated in some cases (e.g. (Kim et al., 
2002)). Since many neurodegenerative diseases are progressive, a third possible kind 
of positive outcome is the protection of the host's tissue, and this too has been reported 
in some occasions (Lee et al., 2008; Tamaki et al., 2009).  
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1.2 - Cell fusion 
 
 
Definition 
 
Cell fusion is the process by which two cells merge to form a single cell. This may 
occur between two cells of the same kind (homotypic cell fusion) or two different cells 
(heterotypic cell fusion) (fig 1.4). As a further distinction, the fused cell can present 
two distinct nuclei (heterokaryon) or the nuclei themselves can fuse, forming a 
synkaryon. This process occurs naturally during development and adulthood, both in 
physiological and pathological conditions. It was originally described in mammalian 
cells in vitro in 1961 (Barski et al., 1961; Sorieul, 1961), but still nowadays is poorly 
understood. Moreover, transplanted cells can undergo fusion with host's elements, and 
this, in some cases, has led to misinterpretation of the experimental results. In the past, 
cell fusion in vivo was regarded as a rare and unpredictable phenomenon, which was 
hard to characterize. In the recent years, especially regarding bone marrow-derived 
cells (BMDCs), considerable research effort was put to have a better understanding of 
the implications and the purpose of cell fusion. 
 
 
Physiological cell fusion 
 
In several organs and tissues, cell fusion is a natural process which contributes to 
the development and the functionality of the structure (for a review, see (Larsson et 
al., 2008)). The fecondation of an egg by the spermatozoa, which gives origin to a 
zygote, is in itself an example of heterotypic cell fusion. Skeletal muscle fibers are 
formed by homotypic fusion of individual myoblasts into multinucleated myotubes. 
Similarly, the fusion between trophoblasts leads to the formation of the placenta. The 
cells in the monocyte/macrophage lineage often fuse to exploit their functions. For 
example, granulomatous infections, such as tubercolosis, lead to fusion between 
macrophages and presence of multinucleated giant cells. Fusion is also required for 
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osteoclasts to form and to exert their function. Microglia, the macrophages of the 
central nervous system (CNS), undergo cell fusion as well (discussed below). 
 
 
Figure 1.4 - Types of cell fusion. Schematic description of the different outcomes of 
cell fusion, depending on the fusion partners and on the behaviour of the two nuclei. In 
some cases, heterotypic fusion can lead to the formation of hybrid cells, with 
characteristic of both parental cells, rather than just one (modified from (Singec and 
Snyder, 2008)). 
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Fusion of bone marrow-derived cells 
  
A big boost to the stem cell field was given by several studies in the early 2000s, in 
which it was described that NSCs could give rise to haemopoetic cells (Bjornson et al., 
1999), and cells from the bone marrow could 'transdifferentiate' into neurons, amongst 
other cell types (Mezey et al., 2000; Morrison, 2001). Apparently, from BMDCs it was 
possible to obtain cells belonging to other lineages, namely cardiac and skeletal 
muscle, hepatocytes, Purkinje neurons and intestinal epithelia. Subsequent research 
revealed that this was indeed an artifact, due to the fusion of the BMDCs with cells in 
the recipient animal. More research effort was then put to elucidate the mechanism and 
the significance of this phenomenon, although in some aspects it is still poorly 
understood. Given the purpose of the present thesis, the attention will be focused on 
the fusion in the CNS.  
First in vitro (Terada et al., 2002) and successively in vivo (Vassilopoulos et al., 
2003; Wang et al., 2003), it was suggested that what was seen after BMDC 
transplantation could originate from fusion, rather than transdifferentiation. 
A more generalized and definitive proof of fusion came later in 2003, when 
Alvarez-Dolado and coworkers (Alvarez-Dolado et al., 2003) demonstrated that 
transplanted BMDCs had fused with the host in the cerebellum, heart and liver of the 
recipient mice. The authors used a Cre/lox method to proof that the transplanted 
BMDCs (which were Cre positive) were transferring their genetic material to some 
cells of the recipient R26R reporter (expressing LacZ after the recombination of a 
floxed stop codon). The only β-galactosidase positive cells were Purkinje neurons, 
cardiomiocytes and hepatocytes, and notably, were often carrying two nuclei. 
Following, contemporary articles have also reported that fusion was responsible for 
the presence of BMDCs-derived cells in the liver (Wang et al., 2003), heart (Nygren et 
al., 2004), skeletal muscle (Rudnicki, 2003) and intestine (Rizvi et al., 2006).  
Concurrently to the aforementioned work, Weimann et al. (Weimann et al., 2003a), 
demonstrated that, after bone marrow transplantation, there was a production of stable 
heterokaryons in the cerebellum, derived from the fusion of BMDCs with Purkinje 
neurons. The resulting cell bore two nuclei, and the one derived from the neuron 
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seemed to have reprogrammed the other, inducing the transcription of Purkinje-
specific genes. The fusion of haemopoietic cells with Purkinje neurons has also been 
demonstrated in humans, analysing postmortem tissue from females transplanted with 
sex-mismatched bone marrow, where the researchers found Y chromosomes in the 
cerebellum (Weimann et al., 2003b).  
One common feature of all these early studies is the fact that the animals were 
lethally irradiated prior to transplantation; this leads to an inflammatory response and, 
in the CNS to the permeabilization of blood-brain barrier, and it has been argued that 
this process in itself would facilitate the fusion. Johansson and co-workers (Johansson 
et al., 2008) using parabiotic mice, demonstrated that this was not the case. In this 
work, one wild-type (wt) and one GFP mouse were connected surgically so that they 
shared the circulatory system and present blood chimaerism. Under these conditions, 
the authors could also find GFP+ Purkinje neurons in the wt mice, even 5 months after 
separation of the parabionts, indicating the stable nature of the fusion. Moreover, they 
investigated extensively the possibility that inflammation could influence the 
frequency of BMDCs fusion with neurons, showing that, depending on the kind of 
stimulus, its occurrence was increased 10-100 fold.  
Similarly, Nygren and coworkers (Nygren et al., 2008), demonstrated that specific 
insults resulted in a concomitant increase of the frequency of fusion in the organ 
involved, even without irradiation. In the CNS, a single injection of ibotenic acid in 
the striatum, led to the presence of fused Purkinje neurons after transplantation to 
levels similar to the once of the irradiated mice. Interestingly, they also showed that 
fusion frequency could be restored to baseline levels after irradiation by the 
administration of an anti-inflammatory drug, prednisolone. Another contribution of 
this paper is the elucidation of the myeloid and lymphoid contributions to the fusion 
process. The authors elegantly used a panel of transgenic mice, combined with 
transplantation in different developmental stages (in utero, neonatal and adult), to 
show that both lineages are responsible for this phenomenon. 
Several other papers highlight that inflammation or irradiation damage is critical in 
eliciting the fusion of transplanted BMDCs. In particular, Nern et al. (Nern et al., 
2009) demonstrated that invasive conditions of various kinds (irradiation or 
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lipopolysaccharide (LPS) injection) are required for the occurrence of stable 
heterokaryons. Interestingly, another article (Espejel et al., 2009) reported fusion 
between cells of the haemopoietic lineage belonging to the host and Purkinje neurons, 
in absence of transplantation. This occurred only when the animals were irradiated, 
and was more pronounced in young animals compared to adults.  
Finally, one isolated article (Hokari et al., 2008), described direct fusion of BMDCs 
with primary neuronal cultures in vitro; the process was fast occuring and of 
considerable proportion, approximately 20% of the culture, was fused after 24h. 
Interestingly, this seemed to have a protective effect when the neurons were exposed 
to toxic doses of glutamate.  
Research on BMDC fusion has contributed to unveiling the fusion phenomenon, 
influencing the whole transplantation field. It has been proven that several factors can 
stimulate fusion in this case, and it is conceivable that this process is not confined to 
these specific cell types. Moreover, from the haemopoietic field came the first proof 
that fusion can have a therapeutic effect, restoring the liver function in genetically 
deficient mice ((Vassilopoulos et al., 2003), discussed below). Nonetheless, very little 
is known about the mechanisms and the biological reasons for the fusion process, and 
consensus is lacking on the methods to detect and monitor its occurrence.  
 
 
Mechanisms of cell fusion 
 
Much of what is known about the molecular mechanisms of cell fusion sprung out 
of research on spontaneous fusion during physiological processes. Although this thesis 
work focuses on fusion in mammals, it is interesting to note that many of these 
phenomena can be paralleled by what happens in yeast mating, nematodes or flies 
(Chen et al., 2007). Cell to cell fusion can be considered a specialized form of 
membrane fusion, which occurs during phagocytosis, secretion and virus infection. 
The influenza virus and human immunodeficiency virus (HIV) possess specific 
proteins (haemoagglutinin (HA) and Env, respectively) devoted to fuse the virus with 
a host's cell, and these proteins resemble SNAREs, involved in exocytosis (Chen and 
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Olson, 2005; Larsson et al., 2008). Intriguingly, one of the first proteins that has been 
described to play a role in cell-cell fusion is syncytin-1, the product of the human 
endogenous retroviral (HERV) W sequence (Larsson et al., 2008). This protein has an 
α-helix bundle structure similar to HA and Env and is responsible for the fusion of 
trophoblasts in the formation of the placenta. Syncytin-2, a product of HERV FRD, 
and the murine versions syncytin-A and -B, also of retroviral origin, have been shown 
to possess similar roles.  
Some proteins involved in the described fusion processes are member of the 
immunoglobulin superfamily: the examples that have been best described are CD47 
and the macrophage fusion receptor (MFR or SIRPα). The first is a protein that is 
ubiquitously expressed, while the latter is present only on cells of the myeloid lineage 
and, notably for the purposes of this thesis, on neurons (Lundberg et al., 2007).  
A recently described example of protein involved in cell fusion is the dendritic cell-
specific transmembrane protein (DC-STAMP) (Yagi et al., 2005), which is 
indispensible for osteoclast formation. DC-STAMP is a seven-transmembrane receptor 
and has structural similarities with two fusion-related proteins of S. Cerevisiae (Ste2 
and Ste3) and with CXCR4, which is needed for HIV fusion.  
Another extracellular interaction, that has been shown to be necessary for fusion in 
some tissues, involves phosphatydilserine (PS); this is a phospholipid normally 
confined in the inner leaflet of the membrane in an ATP-dependent manner. PS is 
considered to be an early apoptotic marker, as it appears on the outer side of the 
membrane when ATP production is disrupted and the cell proceeds to the program of 
cell death. In a number of examples, though, the exposure of PS has been shown to be 
a key feature of cell-cell fusion. During myotube formation, PS goes through cycles of 
exposure and internalization, in non-apoptotic cells (van den Eijnde et al., 2001). The 
authors of the quoted paper demonstrated that this process was necessary for myoblast 
fusion, and could be efficiently inhibited using AnnexinV, a protein that binds to PS, 
in a dose-dependent manner. Similarly Helming and coworkers (Helming et al., 2009) 
demonstrated that PS exposure was crucial for macrophage giant cell formation 
induced by interleukin-4 (IL-4). They also demonstrated that the phospholipid 
interacts with the scavenger receptor CD36, and this bond can be blocked with either 
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AnnexinV and a monoclonal antibody directed against CD36. Interestingly, this 
mechanisms is not present in osteoclast formation, since CD36 KOs present normal 
features.  
As for the mechanism membrane fusion, little is known about the signals that can 
trigger it. Examples of soluble molecules involved in the fusion process are IL-3, IL-4, 
IL-13, macrophage colony-stimulating factor (M-CSF), receptor activator of nuclear 
factor kappa B ligand (RANKL), tumor necrosis factor (TNF) -α, or LPS (Hotokezaka 
et al., 2007). Mostly though, these signals have been shown to augment the frequency 
of fusion, while the mechanism remains unknown.  
Overall, it is possible to notice that there may be no unique cellular machinery 
devoted to cell-cell fusion; rather, different cell types possess their own version of the 
process, with some similarities. Likewise, there are no signals and factors directly 
responsible for the induction of cell fusion, and a large part of the players in this 
phenomenon are still to be discovered.  
 
 
Fusion of neural stem cells 
 
To date, very few reports in the literature have dealt with the fusion of NSCs. A 
first and intriguing report was published in 2002 (Ying et al., 2002), where it was 
shown that it was possible to make NSCs pluripotent by co-culturing them with ESCs. 
By means of crossed selection markers, the authors elegantly demonstrate that this was 
due to fusion and subsequent reprogramming of the NSCs by factors contained in the 
ESCs. Though important for the whole field, this paper does not deal with the fusion 
of the NSCs themselves, but rather with the other and more plastic players, the ESCs.  
More recently, two groups (Chen et al., 2006; Jessberger et al., 2007) have 
demonstrated that NSCs can fuse with each other. Chen et al. showed the presence of 
aneuploid cells after culturing NSCs as monolayers, and confirmed the fusion using a 
Cre/lox approach; this, though, seemed to occur at a low frequency. Jessberger and 
coworkers used instead an approach based on FACS sorting, to isolate and study fused 
cells. The authors retrovirally infected two groups of neurosphere cultures with either 
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GFP or RFP and analyzed the coexpression of the two fluorescent proteins after co-
culture. They demonstrated by FACS that roughly the 0.2% of the culture was double-
labeled, using cells of mouse or rat origin. Moreover, these cells halted their 
proliferative behaviour and could not be propagated.  
These in vitro studies show that NSCs have the potential to fuse with one another, 
although they do it at a very low frequency. Nonetheless, these reports contain no 
information about the possibility that this occurs in vivo, or about the mechanism or 
the significance of this phenomenon.  
 
 
Fusion of microglia 
 
Microglia are the macrophages of the CNS, as they derive from circulating blood-
borne monocytes and invade the nervous system in different times during development 
and pathology (Davoust et al., 2008). They represent the innate immunological cell 
type in the brain.  
Similarly to what described for macrophages, microglia undergo cell fusion to form 
giant cells when subjected to certain stimuli. The first observation of this phenomenon 
was described in relation to HIV infection and AIDS-related dementia (Price et al., 
1988); in the brains of patients, it was possible to find multinucleated microglia, and 
this was due to virus-induced cell fusion. This was then described to happen also in 
vitro, in absence of infection, but in presence of a number of cytokines, namely IL-3, 
IL-4, interferon-γ and GM-CSF (Lee et al., 1993; Suzumura et al., 1999).  
As was described above, most of the information available on cell fusion in the 
CNS derives from the study of transplanted haemopoietic cells. Regarding the fusion 
of BMDCs, it is interesting to note that in many of the aforementioned studies, along 
with the fused cells, the main population of graft-derived cells in the various 
locations,was represented by tissue-specific macrophages, i.e. Kupfer cells in the liver, 
macrophages in the heart and microglia in the brain (Alvarez-Dolado et al., 2003). 
Although it has never been proven that these are ultimately the cells responsible for 
the fusion, this observation is highly suggestive of the involvement of peripheral 
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macrophages in the process. Moreover, as discussed above, it is well known that cells 
of the monocytic lineage have the capability to fuse. Overall, microglia seem to be a 
good candidate as the fusogenic cell type in the CNS.  
The only direct proof of fusion between microglia and mature neurons came in 
2006, when Ackman and coworkers (Ackman et al., 2006) described that this occurred 
in the neocortex of rat neonates after viral injection. Whilst looking for cortical 
neurogenesis using a C-type based retrovirus carrying GFP, which infects only cells in 
M phase of the cell cycle, the authors found several examples of GFP+ pyramidal 
neurons in layers II/III and V of the prefrontal cortex. This effect was very rapid and 
transient, being present only 1 to 20 days after the injection of the virus. Moreover, the 
neurons were BrdU negative, contradicting the assumption that they actually divided. 
Careful analysis of these cells revealed that they often bore a supernumerary nucleus 
on the apical dendrite, which was IB4-positive, indicating it was microglial. The 
authors concluded that the retrovirus was infecting reactive microglia, which 
subsequently fused with the pyramidal neurons. In vitro studies and further analysis 
led them to conclude that this phenomenon was predicated on the presence of the 
retrovirus, though enhanced by the activated status of microglia. This study, shed a 
new light on the roles of microglia in the brain, and opened a new field of 
investigation.  
 
 
Reprogramming of the fused cells 
 
Two cells that undergo fusion share the cytoplasm and have, at least temporarily, 
two nuclei. One very intriguing aspect of cell fusion is that, if the two cells are of 
different origin, one of the two nuclei can be reprogrammed and change its expression 
pattern. It has been known for a long time that cells could be induced to fuse using 
polyethylene glycol (PEG) and the resulting cell would have characteristics of both the 
parental cells; this knowledge led to the development, for example, of monoclonal 
antibodies and the first immortalized NSC lines (Lentz, 2007), as described above. 
Further studies on PEG-induced fusion showed that it induces fast and durable 
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changes in the methylation of the DNA in the heterokaryon (Zhang et al., 2007) and 
bidirectional reprogramming of the nuclei (Palermo et al., 2009). 
The first demonstration that this occurred following spontaneous cell fusion was 
provided by Ying et al. in the work mentioned above (Ying et al., 2002). Using two 
antibiotic-resistance genes as negative selection markers, plus β-galactosidase, GFP 
and gancyclovir sensitivity as positive markers, they showed that NSCs fused with 
ESCs and expressed genes belonging to both the original cell types. These cells 
showed characteristics of ESCs in vitro, and were able to contribute in the formation 
of a mouse embryo when implanted in a blastocyst.  
After descriptions of cell fusion after BMDCs transplantation, several groups 
documented a certain degree of reprogramming in  heterokaryons. Amongst the 
articles already quoted here, Weimann et al. (2003a), described that transplanting 
BMDCs carrying GFP under a Purkinje cell-specific promoter (L7-GFP), it was 
possible to find fused cells expressing GFP. This indicated that, after fusion, the 
BMDC-derived nucleus had been reprogrammed to have a cerebellar expression 
pattern, rather than haemopoietic. Similarly, after transplantation of rat bone marrow 
into mice, Johansson et al. (2008), performed RT-PCR on cerebellar extracts using 
species-specific primers. In this way they demonstrated the expression of Purkinje-
specific genes by the rat nuclei, derived from the BMDCs that had been 
reprogrammed.  
An interesting extension of this concept is the possibility that transplanted cells, 
through fusion, can transfer therapeutic genes to the host. The best described example 
of this is represented by the treatment of a model of tyrosinaemia using BMDC 
transplantation (Vassilopoulos et al., 2003). Mice deficient for fumarylacetoacetate 
hydrolase (Fah-/-) were transplanted with wild type bone marrow. This was sufficient 
for them to regain liver function and discontinue the treatment with NTBC, which 
protects hepatocytes otherwise lost in these animals. The authors demonstrated that the 
fused cells began expressing Fah, downregulating the haemopoietic marker CD45.  
It has been proposed (Pomerantz and Blau, 2004) that reprogramming and 'genetic 
help' after fusion is the biological relevance of this process. Indeed, it is conceivable 
that the presence of the fusion/reprogramming machinery and the resulting expression 
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of appropriate and needed genes, are meant to relieve a cell in a situation of distress. 
More research is needed to elucidate the exact roles of fusion in physiology and 
pathology, and the validity of these speculations.  
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2 - Aims of the Thesis 
 
 
 
This thesis is focused on further elucidating the characteristics of NS cells, an 
innovative in vitro model of neural stem cells. More specifically, the aims we tried to 
fulfill were: 
• To characterize a new line of human striatal NS cells, analysing their in vitro 
 potential and their in vivo behaviour (Paper 1) 
• To investigate in details the in vivo characteristics of ES-derived mouse NS 
 cells (Paper 2) 
• To elucidate the mechanism of cell fusion accompanying NS cell 
transplantation (Paper 2) 
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3 - Human NS cells - Paper 1 
 
 
 
3.1 - Material and Methods 
 
 
Cell culture 
 
Human NS cells derivation and expansion - Dead, aborted fetuses at 7-9 weeks post 
conception were obtained from Lund and Malmö Hospitals according the Lund/ 
Malmö Ethical Committee. Striatal tissue was carefully dissected, incubated for 20-30 
minutes at 37˚C in Euromed-N (Euroclone) and then mechanically dissociated until a 
single cell suspension was obtained. The cells were plated at a density of 105 cells/ml 
in expansion medium, composed of Euromed-N, 1% N2 (Gibco), 2% B27 (Gibco), 20 
ng/ml of EGF and bFGF (R&D System). Primary neurospheres would appear in 18-24 
h. The cells were maintained in the same conditions for 5 to 7 days, passaged after 
dissociation with Accutase (PAA Laboratories) and plated at clonal density. These 
cells would then, in 2-3 days, form secondary neurospheres, and these spheres were 
plated on laminin (10µg/ml, Sigma) coated dishes, giving origin to the monolayer 
culture that we called hNS. They were routinely passaged 1:3/1:5 every 5 to 7 days by 
Accutase treatment to detach them and subsequently re-plating on laminin-coated 
culture dishes.  
In vitro differentiation of hNS - Prior to commencing the differentiation, the hNS 
were plated onto poly-L-ornithine (10µg/ml, Sigma)/laminin-coated chamber slides 
(Labtek, Nunc) and maintained in expansion medium for 2 days. At this point the cells 
were shifted to a differentiation protocol or fixed (see below) to be analysed as a 
control condition. For neuronal induction, the medium was substituted with Euromed-
N containing 0.5% N2, 1% B27 and 20 ng/ml bFGF for 1 week; for an additional 7 
days the cells were cultured in a similar medium, but containing half the dose of bFGF 
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(10 ng/ml). In the third week of differentiation, the medium was composed of a 1:1 
mixture of Euromed-N and Neurobasal (Gibco), with 2% B27, 5 ng/ml bFGF and 5 
ng/ml BDNF (Invitrogen). Subsequently, the cells were cultured one final week in 
Neurobasal containing 2% B27 and 10 ng/ml BDNF. At this stage, the differentiation 
was considered complete and the slides were processed for immunocytochemical 
analysis.  
Preparation of hNS for transplantation - Cultures at 80-90% confluence were 
treated with Accutase to detach the cells, which were then centrifuged, counted and 
resuspended at the density of 100000 cells/µl in Hanks Balanced Saline Solution 
(HBSS) (Gibco). To facilitate the survival of the cells, they were maintained on ice 
throughout the surgical procedure, and for a maximum of 3 hours; the viability of the 
cells was checked before and after each transplantation session by Trypan blue 
(Sigma) staining, and was not significantly affected by the treatment. For a set of 
experiments a retroviral vector was used to label the hNS with GFP (CAG-GFP, see 
(Zhao et al., 2006) for details).  
 
 
Animal procedures 
 
All the experiments in the present thesis were conducted according to the policies 
on the use of animals and guidelines approved by Lund/Malmo Ethical Committee. 
Transplantation of hNS - Two litters of Wistar neonatal rats, post natal day (PD) 2 
to 3, were grafted with hNS in striatum; one with GFP+ and one with unlabeled cells. 
The animals were placed in a cooled Cunningham’s stereotaxic frame and the scull 
surface was aligned in the horizontal plane. The cell suspension (1 µl/deposit) was 
injected unilaterally in to the striatum using a glass capillary (inner diameter 50 µm 
ca) connected to a Hamilton syringe. The following coordinates (mm from Bregma 
and brain surface) were used: anteroposterior (AP) +0.5, lateral (L) -2.0 , ventral (V) -
3.0. The wound was closed with surgical suture and animals were resuscitated by 
slowly increasing body temperature to normal level. The litters were kept together 
with the mother during weaning period and were housed under 12h light–12h dark 
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cycle with ad libitum access to food and water. Animals (n=15) were sacrificed 5 
weeks after transplantation.  
 
 
Immunocyto- and Immunohisto-chemistry 
 
For all in vitro experiments, the cells were fixed using ice-cold 4% 
paraformaldehayde (PFA, Sigma) for 20 minutes; for specific stainings (GABA and 
GLAST) 0.2% glutaraldehyde (Sigma) was added. For the Sox2 stainings, antigen 
retrieval was performed with 1M HCl for 20 minutes at room temperature (RT). After 
washing, the cells were permeabilized in PBS with 0.025% Triton for 10 minutes and 
aspecific binding was blocked using 5% of the appropriate normal serum/sera in PBS 
for 1 hour at RT.  
When processed for histological analysis, the animals were transcardially perfused 
with saline solution first, followed by ice-cold 4% PFA. The tissue was then 
cryoprotected with 20% sucrose before being cut on a freezing microtome. 30 µm 
thick coronal sections were cut and collected in 10 parallel series, all giving the same 
representation of the brain. For staining, the sections were maintained free-floating 
and, after washing, placed in pre-incubation solution (0.25% Triton and 5% normal 
serum/sera in KPBS) for one hour at RT.  
For both cells and sections, primary antibodies were diluted in their respective pre-
incubation solutions and let to react over night at 4˚C; for the Human Nuclei staining, 
the sections were incubated 36-40h at 4˚C. The antibodies used in the present work are 
reported in Table 3.1.  
The primary antibodies were detected with appropriate fluorescent (Cy3 1:300, 
Jackson Immunolabs, or Alexa488 1:400, Invitrogen) or biotinylated (1:200, Vector) 
secondary antibodies, diluted in pre-incubation solution for 2 hours at RT. The 
reaction was eventually developed with fluorophore-conjugated streptavidin (Cy3 
1:300, Jackson Immunolabs or Alexa488 1:200, Invitrogen). Hoechst 33342 (1:1000, 
Invitrogen) was used to label the nuclei, by incubating the samples for 10 minutes at 
the end of the staining procedure.  
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Antigen Raised in  Dilution Provider 
βIII tubulin mouse 1:400 Covance 
βIII tubulin rabbit 1:2000 Covance 
MAP2 mouse 1:500 Sigma 
PSA-NCAM mouse 1:200 Chemicon 
NeuN mouse 1:200 Chemicon 
DCX goat 1:400 Santa Cruz 
Calretinin goat 1:1000 Chemicon 
Calbindin rabbit 1:500 Sigma 
Human Nuclei mouse 1:400 Chemicon 
GFAP rabbit 1:400 Dako 
GFAP mouse 1:500 Sigma 
Ki67 mouse 1:100 Novocastra 
Ki67 rabbit 1:2000 Novocastra 
Vimentin mouse 1:50 Dako 
GLAST guinea pig 1:2000 Chemicon 
human Nestin rabbit 1:200 Chemicon 
Sox2 mouse 1:50 R&D System 
Musashi-1 rat 1:100 prof. H. Okano 
GABA rabbit 1:2000 Sigma 
DARPP-32 mouse 1:200 Serotec 
SC121 mouse 1:2000 StemCell Inc 
GFP rabbit 1:10000 Abcam 
GFP mouse 1:10000 Abcam 
Table 3.1 - List of the antibodies used. 
 
 
hNS - PAPER 1  
41 
Microscopy and quantitative analysis 
 
The specimens were analyzed using either an epifluorescence microscope 
(Olympus BX-61) or laser scanning confocal microscope (Leica); imaging of living 
cells was performed with an Olympus IX-70 inverted microscope. The cell counting of 
the in vitro experiments was carried out by a blinded observer, using a randomized 
sampling system (Computer Assisted Stereological Toolbox, C.A.S.T.-GRID, 
Olympus), counting the cells positive for the different fluorophores and the total of 
Hoechst+ nuclei.  
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3.2 - Results 
 
 
Generation of the monolayer cultures 
 
As described in the methods, human fetal striatal tissue was dissociated and the 
cells plated at clonal density; in 18-24 hours the cells started forming neurospheres, 
which would be cultured for additional 4-6 days. After passage, the secondary 
neurospheres would be let grow for 2-3 days and subsequently plated on laminin-
coated dishes. The cells readily attached and continued proliferating, establishing the 
monolayer culture called hNS from now on. We were able to efficiently repeat this 
procedure starting from tissue coming from different fetuses, obtaining similar 
cultures. The adherent hNS were showing an homogeneous bipolar morphology and 
growing rather quickly, with doubling time of around 2 days (fig 3.1A-D).  
 
 
Characteristics of the proliferating hNS 
 
We performed a series of immunostainings to investigate the nature of the hNS in 
the proliferative state; as mentioned above, these cells tend to divide frequently, 
showing an exponential growth from the very first passages (fig 3.1D). The vast 
majority of the hNS (≈95%) were Nestin positive, and Ki67 (≈35%) was often 
coexpressed (fig 3.1E-H). Along with Nestin we used another general NSC marker, 
Musashi1 (fig 3.1I), which is also widely expressed in the hNS cells. Given the 
previously described radial glial characteristics of the NS cells in general, we 
performed some stainings to evaluate this possibility. The cells resulted virtually all 
positive for Vimentin (fig 3.1J), GLAST (fig 3.1K) and Sox2 (fig 3.2E). Very few 
(≈3.5%) hNS were GFAP positive (fig 3.1L), known marker for human radial glia; this 
is consistent with what was observed by Sun et al. (2008) in their report on human NS 
cells .  
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Figure 3.1 - Derivation and maintainance of the hNS. A, neurospheres from which 
the hNS were derived. B-C, bright field images of hNS in culture. D, quantification of 
the total number of hNS produced from a culture over the passages; note that in the 
first two passages the cells were growing as neurospheres. E-H, double labeling for 
nestin and Ki67, showing the property of neural stem cells of hNS. I-L examples of 
stem cells and radial glial markers expressed by the hNS. Scale bars=50µm 
 
A unique feature of the cells described here is the expression of neuronal markers 
during proliferation. Roughly the 35% of hNS are positive for βIII tubulin in the 
proliferative state; these cells often coexpress markers of proliferation (Ki67, fig 3.2A-
C), NSCs (Sox2, fig 3.2D-F) or radial glia (Vimentin, fig 3.2G-I). A similar 
observation is possible when staining for the neuroblast marker DCX (not shown).  
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Differentiation of hNS 
 
A protocol modified from the ones described in the literature was used to 
differentiate the hNS towards a neuronal fate; the gradual substitution of bFGF with 
BDNF has been proven beneficial to this end (Spiliotopoulos et al., 2009). After 4 
weeks of differentiation we observed a very marked propensity of the hNS to express 
neuronal markers, while astrocytic markers such as GFAP and S100β were either at 
control levels or non expressed, respectively. Around 50% of the cells in the cultures 
were expressing βIII tubulin, MAP2 or DCX (Table 3.2, fig 3.3A-I). A good 
proportion of βIII tubulin positive cells were also positive for the more mature marker 
NeuN, which accounted for the 23% of the total cells (fig 3.3A-C). Another neuroblast 
marker, PSA-NCAM, was also expressed by the differentiated hNS (fig 3.3J-L).  
 
 
Figure 3.2 - Expression of neuronal markers during proliferation. A-C, the arrows 
indicate neuronal cells (βIII tubulin+) which are proliferating (Ki67+). Similarly (D-
F), the immature neurons express the neural stem cell marker Sox2. G-I, coexpression 
of βIII tubulin and Vimentin confirms their ambiguous nature. The arrows indicate 
double positive cells. Scale bars=50µm. 
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Positive cells (% of total) 
Marker 
2 DIV 29 DIV 
Ki67 35.0±7.8  8.7±1.7 
Nestin 95.1±3.2 40.0±7.5 
GFAP 3.4±2.0 6.7±1.5 
βIII tub 34.3±4.0 55.3±5.6 
DCX 24.1±7.0 52.0±4.1 
MAP2 nd 50±6.5 
NeuN nd 23.2±3.5 
Table 3.2 - Expression of markers before and 
after differentiation. The percentage of positive 
cells is calculated over the total of Hoechst+ 
nuclei. (DIV=days in vitro; nd=not detected) 
 
Further analysis of these cells, showed that many (38.5±7.6 %) of them were 
expressing the neurotransmitter GABA (fig 3.4A-C), indicating the nature of the 
neurons formed from hNS. Moreover, a small proportion (<1%) of the cells in the 
culture was expressing neuronal subtype markers such as DARPP-32 (dopamine and 
cAMP regulated phosphoprotein of 32kDa) (fig 3.4D, E) and Calbindin (fig 3.4F). 
 
hNS - PAPER 1  
46 
 
 Figure 3.3 - Neuronal 
differentiation of the 
hNS. A-C, coexpression 
of the neuronal markers 
βIII tubulin and NeuN in 
the cultures after 4 weeks 
of differentiation. Labe-
ling for MAP2 (D-F), 
DCX (G-I) and PSA-
NCAM (J-L) further 
confirms the high content 
in neurons of these speci-
mens; Hoechst stai-ning 
shows the total of the cells 
present. Scale bars=50µm. 
 
Figure 3.4 - GABAergic neurons from hNS cells. A-C, some of the mature neurons 
in the cultures (NeuN+) express the neurotransmitter GABA. Moreover the 
differentiated hNS also expressed DARPP32 (D-E) or Calbindin (F). Scale bars=50µm 
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Transplantation of hNS into the striatum 
 
As described in the methods, 2 groups of newborn rats were transplanted with hNS, 
one with wt cells and the other with hNS transducted with a retrovirus carrying GFP. 
In the first case, we used an immunostaining with an antibody directed against the 
nuclei of human cells (HuNu), to detect the graft; alternatively, we used an antibody 
(SC121) that recognizes a cytoplasmatic epitope in roughly 30-40% of cells of human 
origin, to visualize the morphology of the implanted hNS. We also took advantage of 
the presence of GFP for analysing the morphology of the cells.  
The cells usually arranged themselves in a dense cluster close to the implantation 
site (fig 3.5A); this has been often observed in transplantation studies. Nonetheless, 
many cells migrated out of the core, into the surrounding striatum. In some animals, 
the hNS were disposed along the needle tract; in this case many cells were migrating 
along the corpus callosum. Other white matter tracts, like the striatal bundles, seemed 
to be a preferential place for the hNS, that in some cases were completely confined 
within these structures (see below).  
Five weeks after grafting, the cells markedly reduced their proliferation rate, 
compared to the in vitro behaviour; indeed, it was possible to find only rare Ki67 
positive cells (fig 3.5B-D). Many of the cells in the grafts retained their NSC nature, as 
indicated by the expression of Nestin (fig 3.5E-H).  
In looking for signs of differentiation of the transplanted cells, we first focused on 
their morphology (fig 3.5I-L), using either SC121 or GFP immunohistochemistry. It 
was possible to find cells showing features of neurons (fig 3.5I-J), migrating 
neuroblasts (fig 3.5K) or oligodendrocytes (fig 3.5L).  
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Figure 3.5 - General characteristics of grafted hNS cells. A, low magnification of 
the transplantated cells stained for the human nuclei marker (HuNu). B-D, expression 
of Ki67 by some of the cells (arrow) in the graft. E-G, double labeling for hNestin and 
HuNu, showing home many of the hNS are positive; in H, high magnification of the 
same staining. I-L, morphological analysis of the grafted cells, using the cytoplasmatic 
marker SC121 or GFP. In I and J, cells with features of neurons, characterized by the 
long processes. K, bipolar morphology of a migrating neuroblast. L, processes 
characteristic of oligodendrocytes. Scale bars= 50µm. 
 
To identify the phenotype of the transplanted hNS we used several 
immunostainings, mainly including neuronal markers. Many of the cells in the grafts 
were expressing the neuroblast marker DCX (fig 3.6A-D), indicating that they were 
initiating differentiation towards neurons. Accordingly, most of the hNS in vivo were 
also positive for βIII tubulin (fig 3.6E), while we could not find any cell positive for 
GFAP (fig 3.6F), paralleling what was observed in vitro. Notwithstanding the clear 
neuronal fate of these cells, only very rare NeuN positive hNS were found in the grafts 
(fig 3.6G-I), suggesting longer time would be required in vivo to complete 
differentiation.  
One interesting observation was that the cells placed in the white matter bundles of 
the striatum were strictly limited to these fibers, and showed the distinct morphology 
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of oligodendrocytes (fig 3.6J-L). Given the nature of these structures, it is very 
difficult to distinguish the single oligodendrocytes after immunostaining for specific 
markers; therefore we could not confirm this phenotype in the grafts.  
 
Figure 3.6 - In vivo differentiation of the hNS. A-D, the expression of DCX by the 
grafted cells indicated that they were undergoing neuronal differentiation, confirmed 
by the expression of βIII tubulin (E). F, staining for GFAP failed to label the hNS, 
suggesting that they did not differentiate into astrocytes. G-I, few of the grafted cells 
(arrow) were expressing NeuN, proving to have become mature neurons. J-L, in some 
of the grafts, the cells were confined in the white matter bundles in the striatum 
(evident as NeuN negative in K), and showed oligodendrocytic morphology. Scale 
bars= 50µm.  
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3.3 - Discussion 
 
 
In vitro features of the hNS 
 
The cells described here, similar to others reported earlier, have unique 
characteristics in culture. These include the presence of cells carrying neuronal 
markers in proliferation, the previously reported quantity of neurons obtainable, and 
subtypes present in the differentiated cultures.  
As described in the introduction, the NS culturing system has represented a major 
innovation in the study of NSCs. Three of the features that characterize this kind of 
cells are growth in adhesion, symmetrical division and high yield of neurons after 
differentiation. These characteristics are present in the hNS described here, and it is 
worth elaborating on this.  
We have shown that after plating, the hNS readily attached and began proliferating 
in adhesion, forming homogeneous monolayer cultures. The morphology of the cells 
in vitro remained stable over the passages, as did their other features. We demonstrate 
that the hNS have a high proliferation rate, yielding large numbers of cells with 
relative ease. These are a relevant points, keeping in mind the prospects of cell 
therapy; it is indeed necessary to be able to have a great amount of reproducibly stable 
cells to be able to characterize them in depth before approaching the transplantation in 
animal models, and even more so for patients.  
Although we do not demonstrate directly the fact that the hNS divide 
symmetrically, the fast proliferation and their stability over time are strongly 
suggestive of this kind of division. Regarding the stable growth of these cells, it is 
worth noting that they do not require LIF to be maintained in the long term; probably 
because the NS-culturing system provides enough stimuli to prevent their 
differentiation and/or senescence.  
The hNS cells described in the present study are the cells of this kind, to date, with 
the highest yield in neurons after differentiation. Although the percentage of βIII 
tubulin+ cells in these cultures is comparable with what observed by Sun et al. (∼55 vs 
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∼45%), the frequency of more differentiated cells (NeuN or GABA positive) is 
increased. Moreover, the expression of markers for specific neuronal subtypes, 
suggests their high degree of maturation. The remarkable results obtained by 
Spiliotopoulos et al. (2009) on mouse NS cells (∼85% βIII tubulin+) are not directly 
comparable with human cells, since it is known that these cells take longer time to 
differentiate. Overall, the ease in differentiating our hNS into neurons, along with their 
human origin, make them a very appealing cell strain for a number of in vitro and in 
vivo applications.  
One unique feature of the cells described here is their expression of neuronal 
markers during proliferation. The hNS express βIII tubulin and DCX during 
expansion, and these markers are present in proliferative cells (Ki67 positive). 
Notably, this pattern is consistent along the passages, suggesting that it is a stable 
characteristic of these cells. Moreover, the presence of βIII tubulin/Sox2 and βIII 
tubulin/vimentin double-positive cells confirms that they have a NSC/radial glial 
nature. It is known that neuroblasts can proliferate for a limited amount of time and 
express the aforementioned proteins; nonetheless, it is unlikely that the hNS are 
represented by dividing neuroblasts rather than NSCs. Indeed in this case they would 
rapidly lose their proliferative and neurogenic capacities in culture (Palmer et al., 
1995). This peculiar feature of the hNS cells is possibly an indication of their tendency 
to give origin to neurons, but in any case requires further investigations to elucidate its 
significance.  
Our characterization of the hNS lacks some of the experiments typically conducted 
in establishing a new cell line or strain, namely the clonogenic assay and the 
differentiation into oligodendrocytes. We did not perform the first analysis mentioned 
because these cells required the presence of other cells in the premises, perhaps for 
mutual support by means of cell-cell interaction or paracrine release of factors. It is for 
that reason that they have to be passaged at relatively high density, and be almost 
always at a semi-confluent state. Hence we could not obtain clonal cultures, since the 
cells would have died before forming any colony. Some researchers have bypassed 
this problem using mitotically inactive astrocytes to support the growth of the NSCs 
they were studying (Sun et al., 2008; Koch et al., 2009b). 
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Regarding oligodendrocytic differentiation, our in vivo data (see below) strongly 
suggest that the hNS can give rise to oligodendrocytes. Moreover, it eludes the aims of 
the research conducted in our lab, focused on cell transplantation, especially in stroke 
models, more than on cell biology. The NS culturing system was set up in our group 
with that specific purpose, and in this, the hNS served their scope, giving us an 
interesting cell strain to study in vivo.  
 
 
Characteristics of hNS cells after transplantation 
 
In prospects of cell therapy, it is important to stress that the study of a given cell 
line or strain in vitro can hardly suffice to describe its nature; rather, the culture system 
serves the purpose of showing its potential, or its limitations. For example, Koch et al. 
(2009b) were successful in obtaining several neuronal subtypes in vitro but the cells 
failed to express those markers after transplantation. Also, tumor formation can be 
studied only after grafting, and this too is a basic requirement, for the culture 
environment is radically different from the one the grafted cells find in vivo. Firstly, 
the concentrations of the growth factor used are largely non-physiological, and often 
non-defined media are applied (e.g. FBS). In the dishes, the cells interact primarily 
amongst themselves and possibly they secrete factors, stimulating each other in an 
auto/paracrine fashion (Watt and Hogan, 2000). Finally, the presence of coating in the 
culture vessel, can greatly influence the differentiation of the cells, as shown in many 
studies (e.g. (Spiliotopoulos et al., 2009)), and also this aspect does not match the 
environment in the CNS. 
Hence, transplantation is somewhat of an ultimate challenge for all cells, and the 
means for the researcher to study them. For the grafting of hNS we chose neonatal 
recipients for the advantages mentioned in the introduction; moreover, in our 
laboratory, the rat pups are an established model for the initial characterization of new 
cell types. It is believed that the higher presence of trophic factors and the absence of 
inhibitory signals (Aubert et al., 1995; Caroni, 1998; Qiu et al., 2000) can greatly 
contribute to survival and differentiation of cells implanted in neonates. Therefore, 
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transplantation in these animals permits the study of the characteristics of the cells, 
giving the research the highest chances of highlighting their relevant features, before 
further and focused investigations in adults or models of pathology.  
The hNS described here give an interesting outcome after transplantation. In the 
first place, the cells survive the procedure of grafting; this is a necessary requirement 
for any in vivo study, but it is not to be taken for granted. Indeed, if the cells would 
have been too advanced in their commitment, they would have probably died, like has 
been described in other cases (Minger et al., 1996). On the other hand, we show that 
the hNS slowed their proliferation, and only few cells are still dividing (Ki67 
positive). This observation is in line with the fact that we did not find overgrowth of 
the grafts, nor tumor formation. As described in the introduction, the latter outcome is 
both a concern for the prospective cell therapy and a common problem in this kind of 
studies. Taken together, these first two results of the transplantation studies indicate 
that hNS are suitable for in vivo experiments.  
Regarding the distribution of the cells in the brain, what we observed here is very 
similar to the disposition described earlier for neurosphere cultures transplanted in the 
same fashion (Kallur et al., 2006). Most of the cells remain near to the injection site, 
forming a core and the outlayers migrate inside the striatum's parenchyma. Many of 
the implanted cells have a bipolar morphology, characteristic of migrating cells. A 
particular preference is showed by the hNS for the migration in the white matter tracts, 
as it is believed that these areas are less dense and the movements are facilitated, as 
has been shown before (Tabar et al., 2005).  
We then show that these cells maintain, after grafting, the neurogenic potential they 
have in vitro. Indeed, the vast majority of implanted hNS are DCX- and βIII tubulin-
positive, while they do not express GFAP. It is of note that many of the cells still 
express Nestin, indicating that the differentiation is still ongoing; therefore, it is not 
surprising that we found only very few mature neurons (NeuN+). Longer survival time 
is probably required for the hNS to finish a maturation program and assume a neuronal 
fate, as we have shown previously with human striatal neurosphere transplantation 
(Kallur et al., 2006). Another very interesting characteristic of these cells after 
transplantation, is the differentiation into oligodendrocytes; although we did not 
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confirm it by immunohistochemistry, the morphology and location of the cells is 
extremely suggestive of this fate. Remarkably, these features were observed only in 
the grafted cells located in specific areas of the brain, where oligodendrocytes are 
more abundant, namely corpus callosum and white matter bundles of the striatum. It is 
well known that the formation of oligodendrocytes continues for a long time after 
birth, and conceivably signals are presents in these regions to direct the differentiation 
of specific precursors. The hNS are likely to have the potential to form 
oligodendrocytes in vitro as well, though we did not test this hypothesis; hence, it is 
possible that they can respond to the local environment of the white matter tracts and 
differentiate accordingly.  
 
 
Relevance 
 
In the present work, we describe a new cell strain derived from human fetal 
striatum, called hNS. These cells grow in an adherent monolayer, and they have some 
unique characteristics. The hNS are very prone to formation of neurons in vitro, and 
they show this tendency already in proliferation, expressing neuronal markers. 
Moreover, for the first time we show that NS cells of human origin can be transplanted 
and subsequently differentiate into neurons and oligodendrocytes. As described above, 
similar cells isolated by others do not share these features.  
Overall, we propose that the hNS are cells suitable for transplantation studies, in 
which neuronal replacement is the target achievement. Their human origin, makes 
them an even more interesting model for this field, as prospects of cell therapy are 
predicated on the use of human cells.  
 
 
 
NS CELLS FUSION - PAPER 2 
55 
4 - NS cells fusion - Paper 2 
 
 
 
4.1 Materials and methods 
 
 
Cell culture 
 
Mouse NS cells culture - Mouse embryonic stem cell derived neural stem cells 
(mNS) were maintained as previously described (Conti et al., 2005); they were grown 
on uncoated plastic, in a medium based on Euromed-N, supplemented with 1% N2 and 
20 ng/ml of both EGF and bFGF (called NS-med from now on). Every 3-4 days they 
were detached with Accutase and replated to a dilution of 1:4/1:5, or used in the 
different experiments. The mNS cells were infected with either CAG-GFP or CAG-
RFP retrovirus; in the latter case, the highly expressing population was selected by 
FACS sorting, using BD-FACS Diva. For transplantation, the cells were harvested, 
counted, resuspended at the density of 100000 cells/µl in HBSS and kept on ice for the 
duration of the procedure.  
Microglia culture - A modification of the protocol described by Giulian and Baker 
(Giulian and Baker, 1986) was used to isolate microglia from the neonatal rat or 
mouse brain; in the latter case, we used mice carrying GFP under the chicken β-actin 
promoter (Okabe et al., 1997). Briefly, animals at postnatal day 0-2 were decapitated, 
the brain removed from the skull and placed into ice-cold L15-Lebowitz medium 
(Gibco); the cortices were dissected under sterile conditions and enzimatically 
dissociated for 15 minutes at 37°C in HBSS with 0.015 M, 5.4 mg/ml D-glucose, 1.33 
mg/ml Trypsin (Sigma), 80 U/ml DNase I (Worthington), 0.7 mg/ml hyaluronidase 
(Sigma) and 0.2 mg/ml kynurenic acid (Sigma). The cells were then resuspended in a 
microglia expansion medium (Micro-med), consisting of DMEM/F12 (Gibco), 1% 
Glutamax (Gibco), 10% fetal bovine serum (FBS) (Gibco) and Penicillyne-
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Streptomycine (Gibco), and plated at the density of 100-130000 cells/cm2 on poly-L-
lysine (PLL) (Sigma) coated flasks. The medium was completely changed 1 and 3 
days after the plating; at day 10-12, the cultures were shaken for 45 minutes at room 
temperature, and the medium, rich in microglia, was collected and centrifuged. The 
resulting cells were then counted and plated in Micro-med on PLL-coated 
chamberslides (Labtek, Nunc) or glass coverslips at the density of 20000 cells/cm2. 
The purity of these cultures was verified by immunocytochemistry (see below); they 
were composed for the 93.1±1.4% by microglia (Iba1+), and the remainder contained 
1.0±0.8% astrocytes (GFAP+). In the case of rat microglia, we labeled the cells using 
PKH26 Red Fluorescent Cell Linker Kit (Sigma) according to the manufacturer's 
instructions.  
Primary cells culture - Mouse (β-actin-GFP, E17) or rat (E18) tissue was used to 
isolate the primary cells. In either case, a pregnant animal was euthanized, the 
embryos extracted and maintained in L15 medium on ice for the duration of the 
dissection. The cortices were removed and the tissue digested for 15 minutes at 37°C 
in HBSS containing 0.1% grade II neutral protease (Boehringer Mannheim), 0.01% 
papain (Worthington), and 0.01% DNAse I (Worthington). The cells were then plated 
on poly-D-lysine (10µg/ml, Sigma) and laminin (10µg/ml) coated slides at 20000 
cells/cm2 in medium containing Neurobasal (Gibco), 2% B27 (Gibco), 0.5 mM 
glutamine (Sigma) and penicillin-streptomycin (Gibco) (Pr-med). When required, we 
used PKH26 to label the cells before plating.  
Primary-mNS co-culture - Seven to 12 days after plating the primary cells, the 
cultures were washed with fresh medium and the mNS cells were plated on top (10000 
cells/cm2) in primary cell or NS cell medium. The cultures were maintained 1 to 3 
days thereafter before being analyzed. In these experiments we used either GFP+ 
mouse or PKH26-labeled rat primary cultures with RFP+ or GFP+ mNS cells 
respectively.  
For one set of experiments, rat primary cells were treated with 10nM Mac1-Saporin 
(Advanced Targeting System) or with the control antibody for the 5 days prior to the 
co-culture, and analyzed after 3 days. 
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Microglia-NS co-culture - For these experiments, 20000 microglia/cm2 were plated 
on PLL-coated slides and maintained in Micro-med for 3 to 5 days; mNS cells were 
then plated over the existing culture in NS-med, and the specimens were analyzed 1 to 
5 days after the beginning of the co-culture.  
In one case, mNS cells which had previously killed by 5 freezing/thawing cycles 
were plated on top of a microglia culture, and the specimens were processed after 5 
days; trypan-blue staining was used to confirm that all the cells were dead at time of 
plating.  
When bromo-2-deoxyuridine (BrdU) was used to track the microglia in the co-
culture, the microglia were cultured for 5 days in presence of 10 µM BrdU (BD 
Biosciences), changing the medium daily. Before the co-culture, the medium was then 
changed to the standard one and the excess of BrdU was allowed to wash out for 12 
hours. The co-culture was performed as described above and the cells were fixed 5 
days after plating for immunocytochemical analysis. 
For the AnnexinV experiments, the mNS cells were plated on the microglia culture 
in NS-med containing 2.5%vol/vol of AnnexinV (Invitrogen); to ensure the activity of 
the protein, the medium was replaced with fresh one every other day until the cells 
were fixed on day 5. Medium containing an amount of sodium azide (Sigma) 
equivalent to what present in AnnexinV was used as control condition. 
Primary-microglia co-culture - GFP positive microglia were plated on 7 to 12 days 
old primary cell cultures at a density of 20000 cells/cm2 in Pr-med and analyzed 1 to 3 
days after seeding. A parallel culture of microglia in Pr-med was used to exclude  
differentiation due to culture conditions.  
 
 
Animal procedures 
 
Transplantation of mNS in rat pups - A total of 8 Wistar rat neonates, at post natal 
day (PD) 2 to 3 were transplanted with GFP+mNS; the surgical procedure was 
identical to the one described for hNS cells, but in this case the pups were implanted in 
both cortex and striatum, using the following coordinates: AP +0.5, L -2.0 , V -0.8 
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(cortex) and V -3.0 (striatum) . The animals were sacrificed 1 (n=4) or 4 weeks (n=4) 
after transplantation.   
Transplantation of mNS in mouse pups - Four to 5 day old C57black6 mice were 
used for these experiments; the surgical procedure was similar to the one described for 
rat neonates. In this case we used GFP- or RFP-labeled mNS and used the following 
coordinates (mm from Lambda and brain surface): AP +2.5, L -1.1, V -0.6 (cortex) 
and -1.5 (striatum). These mice were processed 1 (n=3) , 2 (n=3), 4 (n=8), 6 (n=6), or 
8 (n=4) weeks after grafting.  
Lumafluor injection - A group of 4 mouse neonates at PD2 was injected with 0.4 µl  
of Lumafluor RedBeads (Lumafluor Inc) in the left dorsolateral striatum (coordinates 
AP +2.1, L +1.2, V -1.2). According to the manufacturer, 48h after lumafluor injection 
the labeling is completed, and new cells cannot be labeled because it is the injection 
itself that allows the beads to enter the axon (Katz et al., 1984). At PD4 these animals 
were transplanted with GFP+ mNS in the right cortex and striatum as described above. 
The analysis was carried out 8 weeks after surgery. The experimental design is 
illustrated below.  
 
 
Lumafluor experiment. Schematic representation of the rationale of this experiment; 
the animals were injected with RedBeads, and after 2 days mNS were transplantated. 
The co-presence of GFP and Lumafluor indicates the fusion of the cells with host's 
neurons.  
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Immunocyto- and Immunohisto-chemistry 
 
For all in vitro experiments, cells were fixed using ice-cold 4% PFA for 20 
minutes. For BrdU staining, antigen retrieval was performed with 1M HCl for 20 
minutes at room temperature (RT). After washing, cells were permeabilized in PBS 
with 0.025% Triton for 10 minutes and the aspecific binding was blocked using 5% of 
the appropriate normal serum/sera in PBS for 1 hour at RT.  
When processed for histological analysis, animals were transcardially perfused with 
saline solution first and with ice-cold 4% PFA. The tissue was then cryoprotected with 
20% sucrose before being cut on a freezing microtome; 30 µm thick coronal sections 
were cut and collected in parallel series (10 for rats, 8 for mice), all giving the same 
representation of the brain. For staining, sections were maintained free floating and, 
after washing, placed in pre-incubation solution (0.25% Triton and 5% normal 
serum/sera in KPBS) for one hour at RT.  
For both cells and sections, the primary antibodies were diluted in the respective 
pre-incubation solution and let to react over night at 4˚C. The antibodies used in the 
present work are reported in Table 4.1.  
Primary antibodies were detected with appropriate fluorescent (Cy3, Cy5 1:300, 
Jackson Immunolabs, or Alexa488 1:400, Invitrogen) or biotinylated (1:200, Vector) 
secondary antibodies, diluted in pre-incubation solution for 2 hours at RT. The 
reaction was eventually developed with the appropriate fluorophore-conjugated 
streptavidin (Cy3, Cy5 1:300, Jackson Immunolabs or Alexa488 1:200 Invitrogen). 
Hoechst 33342 (1:1000, Invitrogen) or TO-PRO-3 (1:1000, Invitrogen) were used to 
label the nuclei, incubating them for 10 minutes at the end of the staining procedure.  
For the AnnexinV staining, cells were incubated with biotin-conjugated AnnexinV 
(1:50) in an appropriate binding buffer (10 mM HEPES, pH 7.5, 140 mM NaCl and 
2.5 mM CaCl2) for 10 minutes; after washing, fluorescent streptavidin was used to 
detect the AnnexinV; the cells were then fixed as described above. As control for the 
staining, the same procedure was repeated in absence of Ca2+, which is required for the 
binding of AnnexinV.  
 
NS CELLS FUSION - PAPER 2 
60 
 
Antigen Raised in  Dilution Provider 
MAP2 mouse 1:500 Sigma 
NeuN mouse 1:200 Chemicon 
NeuN mouse-(biotin) 1:100 Chemicon 
GFAP rabbit 1:400 Dako 
GFAP mouse 1:500 Sigma 
GFP rabbit 1:10000 Abcam 
GFP mouse 1:10000 Abcam 
GFP chicken 1:3000 Chemincon 
RFP rabbit 1:500 Abcam 
RFP mouse 1:200 Abcam 
M2/M6 rat 1:50 Hybridoma Bank 
Iba1 rabbit 1:1000 Wako 
Iba1 goat 1:200 Chemicon 
BrdU rat 1:100 Accurate 
rat Mac1 mouse 1:100 Serotec 
v-Glut-1 mouse 1:500 Synaptic Systems 
v-Glut-1 rabbit 1:2000 Synaptic Systems 
MBP mouse 1:200 Chemicon 
Olig2 rabbit 1:600 Abcam 
Table 4.1 - List of the antibodies used. 
 
 
Microscopy and quantitative analysis 
 
The specimens were analyzed using either an epifluorescence microscope 
(Olympus BX-61) or laser scanning confocal microscope (Leica); imaging of living 
cells was performed with an Olympus IX-70 inverted microscope. Cell counting for in 
vitro experiments was carried out by a blinded observer, using a randomized sampling 
system (Computer Assisted Stereological Toolbox, C.A.S.T.-GRID, Olympus), 
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counting the cells positive for the different fluorophores and the total of Hoechst+ 
nuclei. For general characterizations, at least 200 cells per slide were counted; at least 
500 cells when quantifying fusion. In the case of the Mac1-Saporin experiments, at 
least 1500 cells were counted. Two-tailed T-test (Prism GraphPad) was used to assess 
the differences between the groups. The data are expressed as mean ± SEM.  
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4.2 - Results  
 
 
Mouse NS give rise to mature neurons after grafting 
 
Four weeks after transplantation of GFP+ mNS cells into the cortex rat neonates, it 
was possible to find two populations of cells in the grafts, very distinct in their 
morphology (fig 4.1A-D). One group was dispersed in a ribbon-like fashion under the 
cortical surface, radiating from the transplantation core. In the other, the GFP+ cells 
displayed the characteristics of mature pyramidal neurons, emitting very long 
dendrites and expressing the neuronal marker NeuN (fig 4.1E-H). This was not true at 
1 week after grafting, where all the GFP+ cells had an immature morphology (not 
shown).  
A similar outcome was observed using mice as recipients, transplanting GFP- or 
RFP-labeled mNS cells into neonates, that were analyzed 1, 2, 4, 6 or 8 weeks after 
grafting. We could find mature neurons positive for the fluorescent proteins only at the 
three latest time points, with the GFP- or RFP-positive pyramidal-like cells disposed 
in the layer V and showing mature dendrites provided of spines (fig 4.1I-L).  
 
 
Fusion of mNS cells 
 
The apparent perfect integration of the grafts led us to suspect that a mechanism of 
transfer of GFP expression alternative to differentiation was involved. We 
hypothesized that the occurrence of the pyramidal cells morphology was due to the 
fusion of the mNS cells with host neurons; in this case these neurons would belong to 
the recipient, and would then have acquired the expression of GFP through the fusion. 
To demonstrate this concept, we analyzed the tissue from the rats transplanted with 
the mNS cells. We used a combination of two species-specific antibodies, M2 and M6, 
which recognize membrane antigens on neurons and macroglia of mouse origin 
(Lagenaur and Schachner, 1981; Lund et al., 1985). The staining performed with these 
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antibodies revealed that the GFP+ pyramidal neurons in the specimens were virtually 
all negative for M2/M6, indicating their rat rather than mouse origin (fig 4.2A-D). All 
the non-neuronal cells in the graft were instead labeled, confirming the efficacy of the 
staining.  
 
 
Figure 4.1 - Mature neurons deriving from mNS cells. A-H, After transplantation 
of GFP+ mNS cells in rat neonates, we could find several cells which displayed a 
pyramidal neuron morphology and were NeuN positive. Similar results came from the 
transplantation of RFP+ mNS cells in mouse neonates (I-L). Scale bars: D=100 µm, H 
and L=20 µm in. 
 
To have additional demonstration of this finding, we performed a set of 
transplantations in animals in which the pyramidal neurons were pre-labeled; in this 
way, we would have confirmed the host origin of the GFP+ neurons in the grafts. A 
retrograde tracer (Lumafluor RedBeads) was injected in the left dorsolateral striatum 
of P2 mice; this resulted in the labeling of several brain areas, including the pyramidal 
neurons in the contralateral cortex (fig 4.2E-G). After two days, when the retrograde 
transport was already completed, GFP+ mNS were transplanted in the right cortex (see 
figure in Material and Methods). Animals were allowed to survive for 8 weeks, and 
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then processed for histology. The presence of both Lumafluor and GFP in some of the 
pyramidal neurons, indicates that they were derived from the recipient animal and not 
from the differentiation of the grafted cells (fig 4.2H-L). 
 
 
Figure 4.2 - Fusion of mNS. A-D, GFP+ mNS cells transplanted stained with the 
mouse-specific antibodies M2/M6; the cells with pyramidal neuron morphology fail to 
be recognized, indicating their rat origin. E-G, example of Lumafluor labeling in 
neurons in the cortex. H, GFP colocalizes with NeuN and Lumafluor, when mNS cells 
are transplanted in an animal previously injected with the label; co-labeling indicates 
that the neuron belongs to the host and is not derived from differentiation; in the 
square is the cell body represented in I-L, with orthogonal views. M-P, in vitro 
evidence of fusion between RFP+ mNS cells and cultured GFP+ neurons (NeuN 
positive). Scale bars: D, G and P=20µm, H=10µm, L=5µm.  
 
In order to better understand these findings, we used an in vitro co-culture system 
to reproduce what we saw in vivo. To do so, we used a culture of primary cells derived 
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from β-actin GFP mouse embryonic cortex; these contained a mixture of neurons 
(79.2 ± 3.7 % MAP2+), astrocytes (10.8 ± 2.3 % GFAP+), microglia (5.6 ± 1.9% 
Iba1+) and virtually no oligodendrocytes. RFP+ mNS cells were plated on these 
cultures, and after 3 days in co-culture, several cells were observed expressing both 
GFP and RFP (5.2 ± 1.2% of total cells ). Moreover, they were also often expressing 
neuron-specific markers, such as NeuN (fig 4.2M-P) or MAP2 (not shown). The 
presence of both GFP and RFP in these cells was a strong indication that the mNS 
cells had fused with cortical neurons present in the primary culture. Similar results 
were obtained using rat primary culture labeled with PKH26 co-cultured with GFP+ 
mNS cells.  
In the context of fusion, for example of BMDCs with Purkinje neurons, it has been 
often shown the presence of two nuclei in the resulting cell (Weimann et al., 2003a), 
although this is not always the case (Nern et al., 2009). Therefore we performed 
careful confocal analysis of the GFP+ pyramidal neurons on sections from mNS-
transplanted rats, and we found that 17.2% of the analyzed cells (10 out of 58 in 3 
different animals) bore two distinct nuclei in the same soma (fig 4.3A). In some cases 
instead, the supernumerary nucleus was located on the apical dendrite of the neuron 
(fig 4.3B-D). Interestingly, not only the pyramidal neurons, but also, more rarely, 
some of the other cells in the graft, notably M2/M6 positive, presented two nuclei (fig 
4.3E-I). 
The presence of both nuclei inside one cell body was also confirmed by 3D 
reconstruction of the confocal images (fig 4.4). 
 
 
 
 
Figure 4.3 (page 66) - Heterokaryon formation in the grafts. A, reconstruction of 
the cell body of one pyramidal neurons by confocal imaging; every column represents 
one focal plane 2 µm apart from the next. The arrows indicate the two distinct nuclei, 
both NeuN positive. B-D, confocal micrographs of one GFP+ pyramidal neuron 
carrying one supernumerary nucleus on the apical dendrite. E-H, GFP and M2/M6 
double-positive cell which contains two nuclei, shown in I in the different focal planes 
and indicated by the arrows. Scale bars: A, H and I=10µm, D=50µm 
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Figure 4.4, legend on page 68.  
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Figure 4.4 (page 67) – Three-dimensional reconstruction of two nuclei inside the 
same cell body. A-D, the pyramidal neuron indicated by the arrow bears two nuclei, 
as demonstrated by the 3D reconstruction in E. Every column represents a different 
plane used for the bidimensional representation of the cell. The two nuclei are circled 
in white. Scale bar D=50µm, E=10µm. 
 
 
Involvement of microglia 
 
In the attempt to characterize the identity of the non-neuronal cells in the graft, we 
performed a staining for Iba1, a microglial marker; surprisingly, given the neural 
nature of the mNS, some of the transplanted cells were Iba1+, both in the rat (fig 4.5 
A-D) and in the mouse (fig 4.5 E-H) sections. In the first case, the Iba1+ cells were 
also positive for the M2/M6 staining, although these antibodies do not bind to mouse 
or rat microglia in vitro (not shown).  
In the light of this finding, we re-analyzed the co-cultures where we observed the 
fusion between mNS and neurons; interestingly, a portion of the double positive cells 
were expressing Iba1 (fig 4.5 I-L), reproducing what we observed in vivo.  
We then hypothesized that the fusion process was mediated by microglia; in this 
case, the mNS cells would fuse with microglia, and these, in turn, would fuse with the 
mature neurons (fig 4.5 M); it is indeed known that microglia are capable of fusing 
with neurons in the cortex (Ackman et al., 2006). To confirm our hypothesis, we 
treated PKH26-labeled rat primary culture with a microglia-specific toxin, Mac1-
saporin, before co-culturing them with the GFP+ mNS cells, ablating virtually all the 
Iba1+ cells in the cultures. Three days after plating the mNS cells on these cultures, 
the number of GFP/PKH26 double-labeled cells was significantly reduced after the 
treatment (0.16±0.09, n=5) compared to the control (3.48±0.19%, n=5) (T-test, 
p<0.0001) (fig 4.5 N and O).  
We then performed another series of in vitro experiments, to study in greater depth 
the role of microglia in mediating the fusion of mNS cells. To do so, we co-cultured 
microglia with mNS cells or microglia with primary cells.  
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Figure 4.5, legend on page 70 
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Figure 4.5 (page 69) - Involvement of microglia in the fusion process. A-D, Triple 
labeling of cells in the grafted rat with GFP, the microglial marker Iba1 and the 
mouse-specific antibodies M2/M6. E-H, RFP/Iba1 double labeling in sections of a 
mouse transplanted with RFP+ mNS. I-L, expression of Iba1 by GFP/PKH26 double 
positive cells after co-culture of GFP+ mNS cells with rat primary cells; the 
orthogonal view in L confirms the triple labeling. M, model of role of microglia in 
mediating the fusion of NS cells and mature neurons. N and O, ablating microglia by 
using Mac1-Saporin, resulted in the almost complete absence of PKH26/GFP double-
labeled cells (arrows) in the co-cultures. Scale bars: D, H and L=20µm, N=50µm 
 
 
Microglia-mNS fusion 
 
One to five days after plating RFP+ mNS cells on GFP+ mouse microglia, it was 
possible to observe a portion of the cells carrying both markers (fig 4.6A-D). To 
exclude that this phenomenon was due to non-specific detection of the fluorophores, 
we pretreated microglia with BrdU; after 5 days of co-culture, we stained the cells for 
BrdU, and we were able to detect cells that were GFP-, RFP- and BrdU-positive (fig 
4.6E-H). As a further confirmation of the fusion, we analyzed the expression of GFP 
and RFP in living cultures. Also in this case we observed double-positive cells (fig 
4.6I-K). To rule out that the acquisition of RFP by microglia was due to aspecific 
phagocytosis, we performed a set of co-cultures using dead mNS cells, in which we 
were unable to find any example of GFP/RFP double-positive cells (not shown). 
Quantification of the different populations in the cultures revealed that the percentage 
of GFP/RFP positive cells was increasing over time (fig 4.6L), suggesting that a 
dynamic process was underlying this finding. Interestingly, 31.8±1.8 % of the double-
positive cells were bearing two distinct nuclei. 
In macrophages (Helming et al., 2009) and myoblasts (van den Eijnde et al., 2001) 
the exposure of phosphatidylserine (PS) is a crucial step of the fusion process, and 
masking of PS by application of AnnexinV inhibits the process. Therefore, we asked 
whether this interaction was contributing to the fusion between microglia and NS 
cells. The staining with AnnexinV revealed that most of the proliferating mNS cells 
expose PS, in absence of cell death (not shown). Moreover we also confirmed that 
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microglia in our cultures expressed the scavenger marker CD36 (not shown), known to 
bind to PS and to be involved in the fusion process (Helming et al., 2009). 
Treatment of the co-cultures with AnnexinV efficiently inhibited the appearance of 
GFP/RFP double-positive cells (8.1±1.1% (n=7) compared to 15.4±2.4% (n=7) in the 
controls, T-test p<0.02), indicating that the fusion between microglia and mNS cells is 
at least in part mediated by the interaction between PS and receptors on the microglia 
counterpart.  
To a have further confirmation of the mNS-microglia fusion, we repeated the co-
cultures using PKH26-labeled rat microglia and GFP+ NS cells. Also in this case we 
were able to find cells carrying both the labels, sometimes having two nuclei (fig 4.6 
M-P). The double-labeled cells expressed microglial markers like Iba1 (not shown) or 
Mac1 (fig 4.6 Q-T), and were stained with M2/M6 (fig 4.6 U-X), indicating that they 
were derived from mNS cells.  
 
 
 
 
 
 
 
 
 
 
Figure 4.6 (page 72) - Fusion between microglia and mNS. A-D, double labeling 
with RFP and GFP after co-culture of RFP+ mNS and GFP+ microglia. E-H, similar 
cocultures, where microglia was pretreated with BrdU, to confirm the specificity of the 
labeling. I-K, images of living cultures, where it was also possible to see the RFP/GFP 
double labeling. L, quantification of the RFP+ cells out of the total GFP+ cells in these 
cultures. M-X, after co-culture of GFP-NS cells with PKH26-labeled microglia, the 
presence of the two fluorophores indicate their fusion. In M-P, the examined cell bears 
two nuclei (arrows). These cells were also express microglial markers (Mac1, Q-T) 
and were recognized by the mouse-specific antibodies M2/M6 (U-X). Scale 
bars=20µm.  
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Figure 4.6, legend on page 71 
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Microglia-neuron fusion 
 
As a final step to demonstrate that microglia mediate the fusion between the mNS 
cells and the mature neurons, we investigated the interaction between neurons and 
microglia themselves. To this end, we co-cultured rat embryonic primary cultures with 
GFP+ mouse microglia for one to three days. As soon as one day after plating, we 
could observe cells expressing, along with GFP, various neuronal markers such as 
MAP2, NeuN and vesicular glutamate transporter 1 (v-Glut-1) (fig 4.7). Some of these 
cells were also Iba1 negative, indicating that, although derived from a pure microglial 
culture, they did not have such characteristics any longer.  
 
 
Figure 4.7 - Fusion of microglia with primary neurons. A-D, after co-culture of 
primary cultures with GFP+ microglia, we observed the presence of GFP/MAP2 
double-positive, Iba1 negative cells (arrowheads). Arrows indicate a normal, non-
fused microglia. The fusion was confirmed by the presence of bi-nucleated neurons 
(NeuN+, arrow) also labeled with GFP (E-H). Moreover, some of the GFP+ cells 
express the glutamatergic neuronal marker v-Glut1 (I-K). Scale bars=20µm.  
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4.3 - Discussion 
 
 
In vivo and in vitro fusion events 
 
In the second part of the thesis is described for the first time the fusion between 
transplanted NSCs and mature neurons in the recipient's cortex. This observation 
sprang out of a routine in vivo study, performed to characterize the behaviour of the 
mouse NS cells we were analysing. After at least 4 weeks post implantation of GFP+ 
mNS cells, we observed mature pyramidal neurons, with the appropriate morphology 
and location, expressing GFP. We confirmed that this apparently perfect 
“differentiation” was not dependent on the species or on the fluorescent protein used 
to label the mNS; indeed we had comparable results transplanting GFP- or RFP-
positive cells in rat or mouse. In all the cases, the graft had two very distinct 
populations. One was represented by the pyramidal neurons, NeuN-positive and 
located in the layers II/III or V of the cortex; the other group of cells was much 
smaller, without a distinctive morphology and NeuN-negative. It is important to note 
that we did not find any single NeuN+ cell that did not have the feature of a pyramidal 
neuron. 
Based both on the experience of our laboratory and on the literature on the topic, 
this perfect differentiation is unusual, to say the least. Partially, because of the time 
course, since 4 weeks are usually not enough for such a robust maturation; the 
formation of spines and long dendrites. Secondly, this type of in vivo behaviour could 
be observed only when transplanting in neonates and only in the cortex, as no neurons 
were found in grafts in adult mice or in neonatal striatum (unpublished observation). 
Such a specific phenomenon is unusual in the transplantation of NSCs; although there 
often are differences, the fate of the implanted cells does not change so radically based 
on the injection site.  
The peculiarity of these observations made us consider the possibility that these 
cells had fused, rather than resulted from differentiation. To demonstrate the fusion, 
we first showed that the pyramidal neurons we observed belonged to the host, and 
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were not graft-derived. To do so, we proceeded in two ways: in rat transplanted with 
mNS, we took advantage of two species/specific antibodies (M2 and M6), which 
recognize antigens on mouse cells. As expected, they failed to stain the pyramidal 
neurons, suggesting that they were not of mouse origin, and hence they were the 
recipient's. It can be argued that the antigens recognized by M2/M6 are down-
regulated after neuronal differentiation. This seems unlikely both because the M6 
antibody is neuron-specific (Lund et al., 1985) and because, in vitro, mouse primary 
cortical neurons can be stained with M2/M6 (unpublished observations).  
To confirm these results, we designed another experiment in which the host's cells 
were pre-labeled; we injected mouse neonates in the left striatum with a retrograde 
tracer, Lumafluor RedBeads, which resulted in the labeling of the ipsi- and contra-
lateral cortices. For this specific tracer, the uptake of the label by the axon terminals 
occurs because of the tissue damage caused by the injection; therefore, new neurons 
projecting in the same area after the time of injection will not be labeled (Katz et al., 
1984). Moreover, the retrograde transport is completed 48 hours after the injection, 
and does not vary over time. Therefore, when we transplanted the mNS 2 days after 
the labeling, it is highly unlikely that the cells picked up the Lumafluor; the distance of 
the site of injection and the characteristic of the tracer, argued against any non-specific 
uptake, due to imprecise surgical procedure or diffusion. Careful analysis of the grafts 
8 weeks after surgery, revealed the presence of some GFP/Lumafluor double-labeled 
cells; this indicated that the GFP was transferred to the pyramidal neurons of the host. 
Although the GFP/Lumafluor double-labeled cells were rare, this still represent a 
proof of principle that the NS cells fuse with the pyramidal neurons. Indeed, the 
retrograde tracer does not label all the resident neurons, and therefore is not present in 
all the GFP+ pyramidal cells.   
We then proceeded to demonstrate another possible consequence of cell fusion: the 
presence of two nuclei. This is not always observed, and in any case is variable across 
the reports in the literature (Weimann et al., 2003a; Kashofer et al., 2006; Duncan et 
al., 2009; Nern et al., 2009; Sumer et al., 2009); nonetheless, as no pyramidal neuron 
is bi-nucleated under normal condition, the occurrence of two nuclei in the GFP+ cells 
is strongly suggestive of a fusion event. Heterokaryon formation in general, is not a 
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requirement for the description of fusion, as mentioned above. Indeed in two cells that 
undergo fusion, nuclei may fuse as well, or one of the two may be lost (see the 
references above for examples). 
To analyse this possibility, we performed accurate confocal imaging on the GFP+ 
pyramidal cells; this revealed the presence of two nuclei in roughly 17% of the 
neurons we examined. In most of the cases, both nuclei were contained within the 
soma, although separated from each other. In a few cells, we could find the 
supernumerary nucleus on the apical dendrite. The fact that this observation was 
relatively rare is not surprising; indeed, the sections we analysed are 30 µm thick, and 
in most cases the entire somato-dendritic axis is not captured within this plane. To 
corroborate this finding, we often observed a nucleus on what dendrite-like structures 
in the layer VI of the cortex. The absence of the cell body in the section does not allow 
for the reconstruction of the connection between the two nuclei. Careful analysis on 
the ploidity of the GFP+ cells, led us to find a few examples of bi-nucleated cells that 
were not pyramidal neurons, but were M2/M6 positive. This observation was crucial 
for the prosecution of the experiments: in fact, it suggested that fusion was not 
confined to the pyramidal neurons. Moreover, it highlighted that the M2/M6 positivity 
was not sufficient to consider a GFP+ cell as un-fused.  
Probably the presence of both heterokaryons and the M2/M6 labeling by 
themselves would lead to an underestimation of the process; we therefore decided to 
use another experimental set up. To have the chance to analyse the fusion between 
mNS and neurons in controlled conditions, we tried to reproduce in vitro what we had 
seen after transplantation. To this end, we considered primary cultures of embryonic 
cortex, of either mouse or rat origin. In either case, the cultures were composed mainly 
of neurons, with a few astrocytes and a small population of microglia. Using 
combination of fluorescent proteins or the membrane label PKH26, we traced the 
primary cells and the mNS after co-culture. Interestingly, in all cases we could find 
double-labeled cells already after 24 hours, accounting for roughly 5% of the cultures 
after 3 days. These cells often had two nuclei (more than 30% of the cases) and some 
of them were NeuN+. It is worth mentioning that we tried to exclude that this was an 
artifactual observation by using both genetic (GFP and RFP) and physical (PKH26) 
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labeling; moreover, we studied the fluorescent proteins with and without 
immunostaining, to exclude unspecific antibody binding. The expression of NeuN was 
also a strong indication of fusion rather than differentiation; indeed, to our knowledge, 
no article reports the differentiation of NSCs into mature neurons in only 3 days.  
Overall, these first experiments showed mNS fuse with elements of the host, and 
this results in the transfer of GFP or RFP expression in mature neurons; the presence 
of two nuclei in both pyramidal neurons and in M2/M6+ cells, suggested that there 
could be another cell type mediating this event. The experiments we then performed 
aimed to elucidate if this was the case, and what was the role of the third player.  
 
 
The role of microglia 
 
To investigate the possibility that we were looking at a two-step process, we first 
started characterizing the cells in the grafts that were not pyramidal neurons by 
immunostaining. Some cells in the grafts were GFAP or MBP positive (not shown), 
indicating their glial nature. This finding came as no surprise, as the mNS can easily 
differentiate into these cell types. What was more unexpected was to find GFP/Iba1+ 
cells; the latter is a marker for microglia, the macrophages of the brain and the 
expression of it in the graft is surprising as the mNS cells are completely committed to 
the neural lineage. We and others (Brilli, E., Conti, L., Cattaneo, E., personal 
communication) have attempted to differentiate  mNS into microglia, with no success. 
Moreover, we observed the same pattern when we transplanted RFP+ mNS into mice, 
confirming again that the phenomena we were studying were not confined to the 
species or the marker used. It is worth mentioning that GFP (or RFP)/Iba1 double-
positive cells were relatively rare, though present in all the specimens already 1 week 
after transplantation. One further unusual finding was that, using rat as the host, we 
could observe GFP/Iba1/M2/M6 triple labeled cells. This result was unexpected 
because M2/M6 do not stain microglia, in any tested condition (in vitro and in vivo) as 
they are specific for neural cells. Nonetheless, the expression of these antigens 
indicated that the cell was showing a somewhat mixed nature, having features of both 
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mNS and microglia. Unfortunately, for technical reason, we could not perform 
confocal analysis on the nuclear content of these cells. To further confirm these 
results, we went back to the in vitro system, and analysed the primary cell/mNS co-
cultures for expression of microglia markers; also in this case, we could find examples 
of cells carrying both the labels of the parental cells (GFP or RFP and PKH26 or GFP) 
and Iba1.  
As described above, microglia are the candidate fusogenic cell type in the CNS, for 
they fuse among each other and might be the mediators of BMDC fusion with Purkinje 
neurons. Even more relevant to the present work is what was described by Ackman et 
al. (2006), who showed fusion of microglia specifically with pyramidal neurons in the 
cortex and in vitro. The numerous similarities between the cited article and our results 
are a further indication that microglia likely play a role in the fusion of mNS cells.  
We hypothesized that microglia were indeed the third intermediate player in the 
fusion process; the mNS cells would fuse with microglia first and then the resulting 
cell would fuse with the pyramidal neuron. To test this, we took advantage of the 
flexibility of the in vitro system, removing the microglia from the primary cultures. If 
the hypothesis was correct, we could reduce or eliminate the presence of fused cells in 
the deriving co-cultures. We used a specific immunotoxin, Mac1-saporin, which is 
composed of a plant toxin, saporin, and an antibody against the rat CD11b (component 
of the complement receptor, expressed by all macrophages). Saporin cannot pass the 
plasma membrane, and therefore is not toxic on its own, but utilizes the antibody to 
enter the cell and exert its inhibitory action on the ribosome, which leads to cell death 
by apoptosis. We tested the efficacy of this toxin on our primary cultures, where we 
could eliminate virtually all microglia, without affecting the other cell types. For this 
experiment, primary cultures were pretreated with Mac1-saporin for 5 days, and then 
the mNS were plated on top; the resulting co-cultures were almost completely devoid 
of PKH26/GFP double-positive cells. These results are a strong proof that the fusion 
we observed in vitro is mediated by microglia. We could not perform a similar 
experiment in the animals, since the action of Mac1-saporin is not complete in vivo 
(unpublished observations); moreover, it is very difficult to exclude the invasion of 
blood borne monocytes/macrophages, even after microglia ablation. Nonetheless, the 
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results from the co-cultures, combined with what we observed in vivo, are a strong 
indication that microglia have a role in the fusion process. Overall, this confirmed of 
our initial hypothesis, of microglia being the bridge between mNS and mature 
neurons. To have a further insight in this concept, we wanted to show that microglia 
themselves could fuse with either of these two elements (mNS and neurons) 
separately, thus demonstrating the two single steps of this process.   
 
 
Insights in the mechanism 
 
As in the initial experiments, we used co-cultures to investigate in further details 
the process of fusion. We first wanted to confirm that microglia themselves can fuse 
with mNS cells; to do so, we plated the mNS on an established culture of microglia, 
using GFP, RFP or PKH26 to trace the cells. In the case of the mouse GFP+ microglia 
cultured with RFP+ mNS, after few days, we could observe several double positive 
cells (up to 15% of the total). As described in the results, the frequency of fused cells 
increased over time, peaking after 5 days of co-culture. To ensure the specificity of 
this observation, we repeated the cultures using dead mNS cells, and did not find any 
GFP/RFP double positive cell, thus confirming that RFP could not be transferred by 
phagocytosis. We also used BrdU to trace the microglia, to rule out aspecific GFP 
detection. Moreover the co-expression of GFP and RFP in single cells was confirmed 
also in living cultures, thus excluding artifacts due to fixation and staining. We could 
observe a similar patter using rat PKH26-labeled microglia with GFP+ mNS; the 
double positive cells expressed also markers characteristic of either of the parental 
cells, namely Iba1, Mac1 or M2/M6. The latter observation is particularly interesting; 
indeed, the fused cells apparently maintained a microglial character (Iba1 and Mac1 
expression), but also the mouse-specific markers. Moreover, mouse microglia do not 
express M2/M6, so the fused cells are somewhat hybrid of the two cells they were 
generated from. This does not rule out that the cells over time would eventually 
downregulate either of the set of genes, assuming one specific fate.  
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We also wanted to find a possible mechanism responsible for the fusion between 
mNS and microglia, and to understand why this phenomenon was specific to this kind 
of NSCs. Indeed, we performed similar co-cultures of microglia with neurosphere 
cultures derived from embryonic mouse cortex, without finding any fused cells. 
Microarray analysis of the expression of membrane proteins, the ones conceivably 
involved in the fusion process, in mNS and neurospheres revealed that these two cell 
types are essentially identical (Brilli, E., Conti, L., Cattaneo, E., personal 
communication). We therefore sought to find an alternative player on the membrane of 
the mNS cells. From the literature, it is known that phosphatidylserine (PS) is involved 
in the fusion of myoblasts (van den Eijnde et al., 2001) and macrophages (Helming et 
al., 2009). To test if this interaction could have been responsible for the mNS-
microglia fusion, we first studied the exposure of PS on the NS cells by AnnexinV 
staining. Although PS is usually regarded as an early sign of apoptosis, in our cells it 
was constantly on the outer leaflet of the membrane, in proliferating and non-apoptotic 
cells. We then tested that microglia expressed the receptor involved in the recognition 
of PS during fusion, CD36, and we could confirm its presence in our cultures. Once it 
was determined that both players had the appropriate molecules on their membrane, 
we proceeded to study the effects of the presence of AnnexinV on the fusion process. 
This protein has a very high affinity for PS, and its binding masks the lipid from 
recognition by other cells. Co-culturing microglia and mNS with AnnexinV in the 
medium efficiently inhibited the fusion, although not completely. The latter aspect 
could be explained in two ways: either our method was not efficient enough in 
masking the PS and the interaction could still occur, or there is more than one 
mechanism involved in the fusion of these cells. In any case, we showed at least one of 
the pathways involved in this process. Moreover, it is interesting to note that PS 
exposure on neurons has been described to be connected to reduced inflammation in 
the CNS and diminished microglial activation (De Simone et al., 2004). This 
observation suggests that PS is important in the microglia-neuron interaction, and 
could be one signal (Grimsley and Ravichandran, 2003; Helming and Gordon, 2009) 
which elicits fusion rather than phagocytosis, perhaps as a protective mechanism. 
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Moreover, in other tissues, it has been proposed that fusion and apoptosis have 
common initiation signals (Huppertz et al., 2001). 
To demonstrate the last step of the fusion, we co-cultured GFP+ microglia directly 
with primary cells, and we looked for the expression of neuronal or microglial marker 
by the GFP+ cells. Although we do not have a direct demonstration of fusion in this 
case, the morphology of the GFP+ cells and the markers they express are a very strong 
indication of such event. Indeed we could detect MAP2, NeuN or v-Glut1 expression 
after as soon as 24 hours of co-culturing. Although there have been some reports of 
microglia differentiating into neurons (Yokoyama et al., 2004), the process was 
occurring over a much longer time and in very particular conditions (70% FBS in the 
medium). To rule out also this possibility, we exposed our microglia cultures to the 
medium used for the co-cultures, and we could not find any sign of neuronal 
differentiation. Moreover, the expression of v-Glut1, a principal neuron marker, 
strongly indicated that fusion might be involved, rather than an aspecific 
differentiation.  
 
 
Implications for the transplantation field 
 
As stated in the introduction, fusion is a natural phenomenon; the scarce knowledge 
on the topic and the lack of efficient methods to detect it, probably account for the lack 
of attention it has achieved. In many cases, including the present study, only the 
occurrence of unusual findings led to the interest to study the possibility that the cells 
fused. For example, the presence of GFP+ Purkinje neurons after BMDCs 
transplantation was totally unexpected and therefore suspicious; similarly, in our 
experiments, the perfect "differentiation" of the mNS into pyramidal neurons made us 
ponder the possibility that it was an artifact. It is conceivable that grafted cells fuse 
more often than reported, but if the results are not particularly unusual, in depth 
investigations are unlikely to follow.  
Along this line, it is worth to mention the role of GFP in the fusion phenomenon; 
indeed we demonstrated that GFP was transferred from the NS cells to microglia and 
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from these to the pyramidal neurons. We also showed that M2/M6 expression is 
maintained after the first fusion process, but not over the second. These two 
observations suggest that one marker is not sufficient to trace grafted cells; indeed, in 
the present work, GFP alone would have led to false positive results, while M2/M6 
staining would not have allowed the visualization of the fused pyramidal neurons. The 
possibility to perform xenotransplantation and use species-specific markers is of great 
value for this kind of study, and allows more in depth study of the possibility that a 
grafted cell fuse. Alternatively, genetic markers could be used, for example using 
transgenic mice as hosts, to then investigate the presence or absence of such markers 
in the grafted cells. The use of a Cre/Lox system is also a very powerful tool to study 
fusion, using a reporter mouse line and Cre+ cells for grafting. It is our belief that 
transplantation studies should be designed in an appropriate way, in order to be able to 
rule out cell fusion as the reason for the results obtained. The elusive nature of this 
process, and the lack of tools to analyse it probably led to its underestimation in many 
studies, and more research is needed to resolve this problem.  
For example, some studies reported remarkable differentiation into mature neurons 
of bone marrow mesenchymal stem cells (Deng et al., 2006), but there is no 
convincing evidence to exclude that this is the result of fusion. In another paper 
(Louboutin et al., 2006), the authors observed in the grafts a massive presence of cells 
with microglial characteristics (CD11b+) at early time points, and then the percentage 
of neurons was increasing; at the light of the results shown in the present thesis, this 
kind of pattern is strongly suggestive of fusion, rather than differentiation. These 
concerns are also reflected in vitro, where cross contamination and fusion can account 
for the "transdifferentiation" observed (Croft and Przyborski, 2006). In some other 
cases, when NSCs were transplanted, the outstanding results the authors sometimes 
report are, in our opinion, a strong indication of fusion rather than differentiation. For 
example Ideguchi et al. (Ideguchi et al., 2010) showed that after transplantation of ES-
derived NSCs, they could find pyramidal neurons with perfect morphology and long-
distance projections as soon as 2-3 weeks after grafting. The authors briefly brush on 
the topic of fusion, but they show only the absence of bi-nucleated cells as proof that it 
did not happen. We show here in our study that the formation of heterokaryons is not a 
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rule following fusion, and thus its absence does not necessarily exclude that the cells 
had fused. These last few examples stress the importance of using different methods to 
study the possibility of fusion events.  
One intriguing idea this study touches upon is that two cells can undergo 
reprogramming after fusion. This has been described in several cases, in some 
examples with a therapeutic outcome (for a review, see (Pomerantz and Blau, 2004)). 
This aspect of cell fusion implies two exciting consequences. First, the possibility of 
administrating a therapeutic gene through transplantation rather than with viral 
vectors; after transplantation the cells would fuse and the gene of interested expressed 
in the specific cell type involved. Even more intriguing is the possibility that the 
fusion itself is a protective or self-repair mechanism. As describe earlier, it has been 
shown for BMDCs transplantation that tissue damage and inflammation increase the 
rate of fusion. It is conceivable that the reason for this is that fusion might have a role 
in the spontaneous healing process, although there is no direct proof that this is the 
case. In this prospect, the role of PS in the cell fusion here described might be an 
indication that microglia fuse with dying (in the classically held view of the word) 
cells; the co-presence of other unknown signals would cause the decision between 
phagocytosis and fusion, the latter being beneficial to the distressed neuron. Although 
these are just speculation, this is a possible explanation for fusion and one which will 
require further investigation.  
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5 - Conclusions 
 
 
 
The present thesis reports new, not previously described, findings on in vitro and in 
vivo behaviour of human and mouse NS cells. The NS-culturing system represent and 
innovative and not yet fully characterized method of deriving and propagating NSCs. 
The particularities of this method reflect themselves into the peculiar characteristics of 
the NS cells.  
 
Regarding the human striatal NS cells reported in the present work, we show that 
they possess unique characteristics in vitro, giving rise to a very high number of 
neurons after differentiation. We also provide the first description of the behaviour of 
such cells after grafting. We demonstrate that the hNS are able to survive and 
differentiate in vivo, showing a remarkable plasticity. The hNS described here are a 
promising cell strain for transplantation studies in animal models of 
neurodegeneration, in prospects of cell therapy.  
 
In the second paper, we demonstrate, for the first time to our knowledge, that 
mouse NS cells fuse in vivo with mature neurons. This is ultimately mediated by 
microglia, in a two-step process. These findings not only shed a new light on the 
functions and roles of microglia, but also provide a cautionary note for all researchers 
doing transplantation studies. The possibility that grafted cells fuse with host cells is 
something that we hope investigators will address in future studies.  
 
Overall, we report here novel features of NS cells; our results are relevant for a 
better understanding of NSCs in general and of their behaviour after transplantation in 
the CNS.  
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